PCT (PCTL) 10-Q 16 Sep 19 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Sep. 12, 2019
Document And Entity Information
Entity Registrant Name	PCT LTD
Entity Central Index Key	0001119897
Document Type	10-Q
Document Period End Date	Jun. 30, 2019
Entity Incorporation, State or Country Code	NV
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity File Number	000-31549
Is Entity's Reporting Status Current?	Yes
Entity Interactive Data Current	Yes
Is Entity Emerging Growth Company?	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Common Stock, Shares Outstanding		240,774,150
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2019

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash	$ 37,298	$ 4,893
Accounts receivable	121,129	49,140
Inventory	6,461	7,105
Prepaid expenses	41,019	218,494
Other Assets	2,110	2,110
Total current assets	208,017	281,742
PROPERTY AND EQUIPMENT
Property and equipment, net	489,787	499,972
OTHER ASSETS
Intangible assets, net	3,860,873	4,059,775
Operating lease right-of-use asset	19,695
Deposits	5,499	5,499
Total other assets	3,886,067	4,065,274
TOTAL ASSETS	4,583,871	4,846,988
CURRENT LIABILITIES
Accounts payable	384,860	350,593
Accrued expenses - related parties	62,278	54,033
Accrued expenses	488,841	362,436
Operating lease liability	21,704
Deferred revenue	24,532
Current portion of notes payable - related party	819,863	93,000
Current portion of notes payable, net	406,306	399,664
Current portion of convertible notes payable, net	488,141	161,280
Derivative liability	3,349,099	322,976
Preferred series A stock liability		144,352
Total current liabilities	6,045,624	1,888,334
LONG TERM LIABILITIES
Notes payable - related parties, net of current portion and discounts		733,826
Notes payable, net of current portion and discounts		126,707
Convertible notes payable, net of current portions and discounts	7,909	392,534
TOTAL LIABILITIES	6,053,533	3,141,401
MEZZANINE EQUITY
Preferred stock series A, $0.001 par value; 1,000,000 authorized; 500,000 and nil issued and outstanding at June 30, 2019 and December 31, 2018, respectively	60,398
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock, $0.001 par value; 300,000,000 authorized; 76,859,961 and 44,559,238 issued and outstanding at June 30, 2019 and December 31, 2018, respectively	76,860	44,560
Additional paid-in capital	12,770,553	11,588,030
Accumulated deficit	(14,377,473)	(9,927,003)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	(1,530,060)	1,705,587
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 4,583,871	$ 4,846,988

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Preferred stock series A, par value	$ 0.001	$ 0.001
Preferred stock series A, shares authorized	1,000,000	1,000,000
Preferred stock series A, shares issued	500,000
Preferred stock series A, shares outstanding	500,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	76,859,961	44,559,238
Common stock, shares outstanding	76,859,961	44,559,238

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
REVENUES
Product	$ 11,745	$ 50,572	$ 98,839	$ 73,213
Licensing	34,000		78,500
Equipment leases	73,117	19,500	137,480	39,000
Total revenue	118,862	70,072	314,819	112,213
OPERATING EXPENSES
General and administrative	419,131	613,569	1,086,095	1,058,794
Costs of product, licensing and equipment	24,077	4,756	96,731	20,474
Depreciation and amortization	84,189	80,162	169,101	166,858
Total operating expenses	527,397	698,487	1,351,927	1,246,126
Net loss before other expenses	(408,535)	(628,415)	(1,037,108)	(1,133,913)
OTHER INCOME (EXPENSES)
Loss on change in fair value of derivative liability	(2,789,342)		(2,951,641)
Gain (loss) on change in fair value of preferred series A stock liability	(3,004)		72,473
Gain on sale of intangible assets	52,498		52,498
Loss on settlement of debt			(84,409)
Interest expense	(381,764)	(39,644)	(502,283)	(65,448)
Total other income (expenses)	(3,121,612)	(39,644)	(3,413,362)	(65,448)
Loss from operations before income taxes	(3,530,147)	(668,059)	(4,450,470)	(1,199,361)
Income taxes
NET LOSS	$ (3,530,147)	$ (668,059)	$ (4,450,470)	$ (1,199,361)
Basic and diluted net loss per share	$ (0.07)	$ (0.02)	$ (0.09)	$ (0.03)
Basic and diluted weighted average shares outstanding	52,755,139	43,407,809	49,208,103	42,541,614

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash Flows from Operating Activities
Net loss	$ (4,450,470)	$ (1,199,361)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	169,101	166,858
Amortization of debt discount	300,703	15,470
Amortization of operating lease right-of-use asset	23,635
Common stock issued for services	122,052	295,904
Loss on change in fair value of derivative liability	2,951,641
Gain on change in fair value of preferred series A stock liability	(72,473)
Loss on settlement of debt	84,409
Gain on sale of intangible assets	(52,498)
Changes in operating assets and liabilities:
Accounts receivable	(81,166)	(27,274)
Inventory	644	(17,493)
Prepaid expenses	177,475	3,371
Other assets		(44,500)
Operating lease liability	(21,626)
Accounts payable	59,265	3,703
Accrued expenses - related party	8,245	17,125
Accrued expenses	303,311	95,812
Deferred revenue	24,532
Net cash used in operating activities	(453,220)	(690,385)
Cash Flows from Investing Activities
Proceeds from sale of intangible assets	57,500
Purchase of property and equipment	(2,516)	(3,900)
Purchase of intangible assets	(5,000)	(5,000)
Net cash provided by (used in) investing activities	49,984	(8,900)
Cash Flows from Financing Activities
Proceeds from notes payable - related parties	2,544	54,000
Proceeds from notes payable	88,600	287,500
Proceeds from convertible notes payable	460,750	265,000
Proceeds from issuance of common stock		115,000
Repayment of notes payable - related parties	(16,044)	(10,000)
Repayment of notes payable	(9,209)	(20,000)
Repayment of convertible notes payable	(91,000)
Net cash provided by financing activities	435,641	691,500
Net change in cash	32,405	(7,785)
Cash and cash equivalents at beginning of period	4,893	7,838
Cash and cash equivalents at end of period	37,298	53
Supplemental Cash Flow Information:
Cash paid for interest	51,639	14,750
Cash paid for Income taxes
Non-Cash Investing and Financing Activities
Debt discounts on notes payable – related parties		20,000
Debt discounts on notes payable	10,204	13,464
Debt discounts on convertible notes payable	395,125	78,087
Modification of notes payable	20,590
Common stock issued in conversion of convertible notes payable	287,376
Accounts receivable netted against notes payable	18,000
Initial operating lease right-of-use asset and liability	43,330
Default penalty on convertible notes payable	87,500
Preferred series A stock reclassification from liability to mezzanine equity	60,398
Extinguishment of notes payable		250,000
Common stock issued for prepaid expenses		$ 1,028,000

Consolidated Statements of Stoc

Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2017	41,179,238
Beginning balance, amount at Dec. 31, 2017	$ 41,180	$ 10,001,323	$ (6,744,520)	$ 3,297,983
Common stock issued for cash, shares	110,000
Common stock issued for cash, amount	$ 110	54,890		55,000
Common stock issued for services, shares
Common stock issued for services, amount		43,836		43,836
Beneficial conversion feature		58,401		58,401
Net loss			(531,302)	(531,302)
Ending balance, shares at Mar. 31, 2018	41,289,238
Ending balance, amount at Mar. 31, 2018	$ 41,290	10,158,450	(7,275,822)	2,923,918
Beginning balance, shares at Dec. 31, 2017	41,179,238
Beginning balance, amount at Dec. 31, 2017	$ 41,180	10,001,323	(6,744,520)	3,297,983
Net loss				(1,199,361)
Ending balance, shares at Jun. 30, 2018	43,459,238
Ending balance, amount at Jun. 30, 2018	$ 43,460	11,217,130	(7,943,881)	3,316,709
Beginning balance, shares at Mar. 31, 2018	41,289,238
Beginning balance, amount at Mar. 31, 2018	$ 41,290	10,158,450	(7,275,822)	2,923,918
Common stock issued for cash, shares	120,000
Common stock issued for cash, amount	$ 120	59,880		60,000
Common stock issued for services, shares	2,050,000
Common stock issued for services, amount	$ 2,050	982,114		984,164
Beneficial conversion feature		16,686		16,686
Net loss			(668,059)	(668,059)
Ending balance, shares at Jun. 30, 2018	43,459,238
Ending balance, amount at Jun. 30, 2018	$ 43,460	11,217,130	(7,943,881)	3,316,709
Beginning balance, shares at Dec. 31, 2018	44,559,238
Beginning balance, amount at Dec. 31, 2018	$ 44,560	11,588,030	(9,927,003)	1,705,587
Common stock issued for services, shares	575,000
Common stock issued for services, amount	$ 575	98,352		98,927
Common stock issued in settlement of debt, shares	5,383,810
Common stock issued in settlement of debt, amount	$ 5,383	800,012		805,395
Net loss			(920,323)	(920,323)
Ending balance, shares at Mar. 31, 2019	50,518,048
Ending balance, amount at Mar. 31, 2019	$ 50,518	12,486,394	(10,847,326)	1,689,586
Beginning balance, shares at Dec. 31, 2018	44,559,238
Beginning balance, amount at Dec. 31, 2018	$ 44,560	11,588,030	(9,927,003)	1,705,587
Net loss				(4,450,470)
Ending balance, shares at Jun. 30, 2019	76,859,961
Ending balance, amount at Jun. 30, 2019	$ 76,860	12,770,553	(14,377,473)	(1,530,060)
Beginning balance, shares at Mar. 31, 2019	50,518,048
Beginning balance, amount at Mar. 31, 2019	$ 50,518	12,486,394	(10,847,326)	1,689,586
Common stock issued for services, shares
Common stock issued for services, amount		23,125		23,125
Common stock issued in conversion of convertible notes payable, shares	26,341,913
Common stock issued in conversion of convertible notes payable, amount	$ 26,342	261,034		287,376
Net loss			(3,530,147)	(3,530,147)
Ending balance, shares at Jun. 30, 2019	76,859,961
Ending balance, amount at Jun. 30, 2019	$ 76,860	$ 12,770,553	$ (14,377,473)	$ (1,530,060)

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The unaudited interim condensed consolidated financial statements of PCT LTD (the “Company”) have been prepared in accordance with United States generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and reflect all adjustments which, in the opinion of management, are necessary for a fair presentation of our balance sheet, statements of operations, stockholders’ equity, and cash flows for the periods presented. All such adjustments are of a normal recurring nature. The results of operations for the interim period are not necessarily indicative of the results to be expected for a full year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2018 audited financial statements as reported in its Form 10-K, filed on April 15, 2019. Nature of Operations PCT LTD (formerly Bingham Canyon Corporation, (the “Company,” “PCT Ltd,” or “Bingham”), a Delaware corporation, was formed on August 27, 1986. The Company changed its domicile to Nevada on August 26, 1999. On August 31, 2016, the Company entered into a Securities Exchange Agreement with Paradigm Convergence Technologies Corporation (“Paradigm”) to affect the acquisition of Paradigm as a wholly-owned subsidiary. Under the terms of the agreement, Bingham issued 16,790,625 restricted common shares of Bingham stock to the shareholders of Paradigm in exchange for all 22,387,500 outstanding common shares of Paradigm stock. In addition, Bingham issued options exercisable into 2,040,000 shares of the Bingham’s common stock (with exercise prices ranging between $0.133 and $0.333) in exchange for 2,720,000 outstanding Paradigm stock options (with exercise prices ranging between $0.10 and $0.25). These 2,040,000 options have been adjusted at the same exchange rate of 75% that the outstanding common shares were exchanged. As a result of this share exchange agreement, Paradigm, the operating company, is considered the accounting acquirer. Paradigm is located in Little River, SC and was formed June 6, 2012 under the name of EUR-ECA, Ltd. On September 11, 2015, its Board of Directors authorized EUR-ECA Ltd to file with the Nevada Secretary of State to change its name to Paradigm Convergence Technologies Corp. Paradigm is a technology licensing company specializing in environmentally safe solutions for global sustainability. The company holds a patent, intellectual property and/or distribution rights to innovative products and technologies. Paradigm provides innovative products and technologies for eliminating biocidal contamination from water supplies, industrial fluids, hard surfaces, food processing equipment, and medical devices. Paradigm’s overall strategy is to market new products and technologies through the use of equipment leasing, joint ventures, licensing, distributor agreements and partnerships. Effective on February 29, 2018, the Company changed its name from Bingham Canyon Corporation to PCT LTD to more accurately identify the Company’s direction and to develop the complimentary relationship and association with its wholly-owned operating company, Paradigm Convergence Technologies Corporation (“Paradigm” or “PCT Corp.”). Principles of Consolidations The accompanying consolidated financial statements include the accounts of PCT LTD (“Parent”) and its wholly owned subsidiary, Paradigm Convergence Technologies Corporation (“Paradigm” or “Subsidiary”). All intercompany accounts have been eliminated upon consolidation. Use of Estimates The preparation of the condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingencies at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting periods. Estimates are based on historical experience and on various other market-specific and other relevant assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates. Cash and Cash Equivalents Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. The cash of $37,298 and $4,893 as of June 30, 2019 and December 31, 2018, respectively, represents cash on deposit in various bank accounts. There were no cash equivalents as of June 30, 2019 and December 31, 2018. Fair Value Measurements The Company follows ASC 820, “Fair Value Measurements and Disclosures,” which defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. A fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last is considered unobservable, is used to measure fair value: • Level 1 - Valuations for assets and liabilities traded in active markets from readily available pricing sources such as quoted prices in active markets for identical assets or liabilities. • Level 2 - Observable inputs (other than Level 1 quoted prices) such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. • Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The carrying values of our financial instruments, including, cash and cash equivalents, accounts receivable, inventory, prepaid expenses, accounts payable and accrued expenses approximate their fair value due to the short maturities of these financial instruments. Derivative liabilities and preferred series A stock liabilities are determined based on “Level 3” inputs, which are significant and unobservable and have the lowest priority. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations. Our financial assets and liabilities carried at fair value measured on a recurring basis as of June 30, 2019, consisted of the following: Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Derivative liability (1) 3,349,099 — — 3,349,099 Total 3,349,099 — — 3,349,099 Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2018, consisted of the following: Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Preferred series A stock liability (1) 144,352 — — 144,352 Derivative liability (1) 322,976 — — 322,976 Total 467,328 — — 467,328 (1) The Company has estimated the fair value of these liabilities using the Binomial Model. Derivative and Preferred Series A Stock Liabilities The Company accounts for derivative instruments in accordance with ASC Topic 815, “ Derivatives and Hedging Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial statement. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. See Note 7 for additional information. Accounts Receivable Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. The Company provided allowances for uncollectible accounts receivable equal to the estimated collection losses that will be incurred in collection of all receivables. Accounts receivable is periodically evaluated for collectability bases on past credit history with customers and their current financial condition. The Company’s management determines which accounts are past due and if deemed uncollectible, the Company charges off the receivable in the period the determination is made. Based on management’s evaluation, the Company provided an allowance for doubtful accounts of $0 at June 30, 2019 and December 31, 2018, respectively. Inventories Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method. We record the value of our inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand, future pricing and market conditions. As of June 30, 2019 and December 31, 2018, the inventory consisted of parts for equipment sold as replacement parts to existing customers or sold to new customers. The Company has recorded a reserve allowance of $0 and $0 as of June 30, 2019 and December 31, 2018, respectively. The Company has determined that some of the supplies inventory is necessary to be placed into service, after assembly into equipment to be used in product manufacturing and classified as Machinery and Equipment. The balance at June 30, 2019 and December 31, 2018 of such supplies and equipment not yet placed in service amounted to $306,225 and $319,735, respectively. Property and Equipment Property and equipment are stated at purchased cost and depreciated utilizing a straight-line method over estimated useful lives ranging from 3 to 7 years after the asset has been placed in service. Upon selling equipment that had been under a lease agreement, the company discontinues the depreciation on that piece of equipment, as it transfers ownership to another entity. Additions and major improvements that extend the useful lives of property and equipment are capitalized. Maintenance and repairs are charged to operations as incurred. Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any related gains or losses are recorded in the results of operations. Impairment of Long-lived Assets The carrying values of the Company’s long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the fair value. Under similar analysis no impairment was recorded during the six months ended June 30, 2019. Intangible Assets Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology. Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 1 to 15 years. An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The recorded impairment expense was nil for the six months ended June 30, 2019. Research and Development Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable. Leases In February 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-02, Leases (Topic 842) ("ASC 842"), which requires lessees to recognize right-of-use ("ROU") assets and related lease liabilities on the balance sheet for all leases greater than one year in duration. We adopted ASC 842 on January 1, 2019 using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach did not require any transition accounting for leases that expired before the earliest comparative period presented. The adoption of this standard resulted in the recording of ROU assets and lease liabilities for our lease agreements with original terms of greater than one year. Upon implementation, the Company recognized an initial operating lease right-of-use asset of $43,330 and operating lease liability of $43,330. Due to the simplistic nature of the Company's leases, no retained earnings adjustment was required. See Note 5 for further details. Revenue Recognition On May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customer (Topic 606) The Company has the following three revenue streams: 1) product sales (equipment and/or fluid solutions); 2) licensing (contract-based use of the Company’s US EPA Product Registration, returning revenue in licensing fees and/or royalties from minimum or actual fluid sales); and 3) equipment leases (under systems service agreements, usually 3-year contracts for the provision of the Company’s equipment and service of such, under contract to customers, with renewable terms). The Company recognizes revenue from the sale of products when the performance obligation is satisfied by transferring control of the product to a customer. The Company recognizes revenue from the leasing of equipment as the entity provides the equipment and the customer simultaneously receives and consumes the benefits through the use of the equipment. This revenue generating activity would meet the criteria for a performance obligation satisfied over time. As a result, the Company recognizes revenue over time by using the output method, as the Company can measure progress of the performance obligation using the time elapsed under each obligation. The Company’s licenses provide a right to use and create performance obligations satisfied at a point in time. The Company recognizes revenue from licenses when the performance obligation is satisfied through the transfer of the license. For licenses that include royalties the Company will recognize royalty revenue as the underlying sales or usages occur, as long as this approach does not result in the acceleration of revenue ahead of the entity’s performance. The Company has disclosed disaggregated revenue via revenue stream on the face of the statement of operations. The Company did not have any contract assets or liabilities at June 30, 2019. Basic and Diluted Loss Per Share Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. As of June 30, 2019, there were outstanding common share equivalents (options, warrants, convertible debt and preferred series A stock) which amounted to 721,585,416 shares of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive. Recent Accounting Pronouncements The Company has reviewed all other FASB issued ASU accounting pronouncements and interpretations thereof that have effective dates during the period reported and in future periods. The Company has carefully considered the new pronouncements that alter the previous GAAP and do not believe that any new or modified principles will have a material impact on the Company’s reported financial position or operations in the near term.

GOING CONCERN

GOING CONCERN	6 Months Ended
	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2. GOING CONCERN The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception of $14,377,473 and has negative cash flows from operations. As of June 30, 2019, the Company had a working capital deficit of $5,837,607. The Company has relied on raising debt and equity capital in order to fund its ongoing day-to-day operations and its corporate overhead. The Company will require additional working capital from either cash flow from operations, from debt or equity financing, or from a combination of these sources. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a period of one year from the issuance of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	6 Months Ended
	Jun. 30, 2019
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 3. PROPERTY AND EQUIPMENT Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from 3 to 7 years once placed into service. Depreciation expense does not begin until documentation of equipment placed in service is provided. Machinery and leased equipment is not intended to be sold to the customer at the end of the lease term. Depreciation expense was $12,701 and $12,946 for the six months ended June 30, 2019 and 2018, respectively. Property and equipment at June 30, 2019 and December 31, 2018 consisted of the following: June 30, 2019 December 31, 2018 Machinery and leased equipment $ 151,719 $ 138,209 Machinery and equipment not yet in service 358,760 369,754 Office equipment and furniture 20,064 20,064 Website 2,760 2,760 Total property and equipment $ 533,303 $ 530,787 Less: Accumulated Depreciation (43,516 ) (30,815 ) Property and equipment, net 489,787 499,972

INTANGIBLE ASSETS

INTANGIBLE ASSETS	6 Months Ended
	Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	NOTE 4. INTANGIBLE ASSETS Amortization is computed using the straight-line method and is recognized over the estimated useful lives of the intangible assets, which range from 1 to 15 years. Amortization expense was $156,400 and $153,912 for the six months ended June 30, 2019 and 2018, respectively. Intangible assets at June 30, 2019 and December 31, 2018 consisted of the following: June 30, 2019 December 31, 2018 Patents $ 4,505,489 $ 4,514,989 Technology rights 200,000 235,500 Intangible, at cost 4,705,489 4,750,489 Less: Accumulated amortization (844,616 ) (690,714 ) Net Carrying Amount $ 3,860,873 $ 4,059,775 Estimated Future Amortization Expense: $ For year ending December 31, 2019 155,168 For year ending December 31, 2020 303,613 For year ending December 31, 2021 302,003 For year ending December 31, 2022 302,003 For year ending December 31, 2023 to December 31, 2034 2,798,086 Total 3,860,873 On May 10, 2019, the Company sold intangible assets with a carrying value of $92,502 for $111,323 of cash of which $53,823 was received subsequent to June 30, 2019, and the settlement of $33,677 of liabilities owed to the buyer. The Company recorded a gain on sales of intangible assets of $52,498.

LEASES

LEASES	6 Months Ended
	Jun. 30, 2019
Debt Disclosure [Abstract]
LEASES	NOTE 5 – LEASES In February 2016, the FASB issued ASU No. 2016-02, Leases The depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term. The Company's leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The Company used incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date. The following table sets forth the ROU assets and liabilities as of June 30, 2019: June 30, 2019 Operating lease right-of-use asset $ 19,695 Operating lease liability: Current operating lease liability $ 21,704 Noncurrent operating lease liability — Total operating lease liability $ 21,704 Expense related to leases is recorded on a straight-line basis over the lease term, including rent holidays. During the six months ended June 30, 2019, the Company recognized operating lease expense of $30,809. Operating lease costs are included within selling, administrative and other expenses on the condensed consolidated statements of income. Cash paid for amounts included in the measurement of operating lease liabilities were $28,800 for the six months ended June 30, 2019. During the six months ended June 30, 2019, the Company reduced its ROU liabilities by $21,626 from cash paid. Our weighted average discount rate is 41% and the weighted average remaining lease term is 5 months. Lease payments over the next five years and thereafter are as follows: June 30, 2019 2019 - remaining $ 24,000 2020 and thereafter — Total lease payments 24,000 Less: imputed interest (2,296 ) Total ROU liabilities $ 21,704 As previously disclosed in our 2018 Form 10-K under the prior guidance of ASC 840, minimum payments under operating lease agreements as of December 31, 2018 were as follows: December 31, 2018 2019 $ 52,950 2020 — Total $ 52,950

NOTES PAYABLE

NOTES PAYABLE	6 Months Ended
	Jun. 30, 2019
Debt Disclosure [Abstract]
NOTES PAYABLE	NOTE 6. Notes Payable The following tables summarize notes payable as of June 30, 2019 and December 31, 2018: Type Amount Origination Date Maturity Date Annual Interest Rate Balance at June 30, 2019 Balance at December 31, 2018 Note Payable*** $ 150,000 5/18/2016 6/1/2019 19.00 % $ 150,000 $ 150,000 Note Payable *** $ 25,000 5/8/2017 6/30/2018 0.00 % $ 27,500 $ 27,500 Note Payable $ 130,000 6/20/2018 1/2/2020 8.00 % $ 130,000 $ 130,000 Note Payable (a) $ 126,964 6/20/2018 8/31/2018 6.00 % $ — $ 126,964 Note Payable (b) $ 26,500 6/26/2018 10/1/2019 10.00 % $ 10,090 $ 26,500 Note Payable (g) $ 60,000 10/30/2018 12/30/2018 8.00 % $ — $ 60,000 Note Payable *** $ 8,700 11/15/2018 6/30/2019 10.00 % $ 8,700 $ 8,700 Note Payable (c) $ 52,063 4/8/2020 4/8/2020 41.38 % $ 42,854 $ — Note Payable (d) $ 40,000 6/20/2019 12/31/2019 8.00 % $ 40,000 $ — Note Payable (e) $ 6,741 6/21/2019 4/8/2020 41.38 % $ 6,741 $ — Subtotal $ 415,885 $ 529,664 Debt Discount $ (9,579 ) $ (3,293 ) Balance, net $ 406,306 $ 526,371 Less current portion $ (406,306 ) $ (399,664 ) Total long-term $ — $ 126,707 *** Currently in default a) On January 28, 2019, the Company agreed to convert $131,327 of principal and interest of its note payable with a non-related party into 987,421 shares of the Company’s common stock. The company recorded a loss on settlement of debt of $38,319 equal to the difference between the fair value of the common shares of $177,736 and the carrying value of the note and interest. b) On February 1, 2019, the Company modified note by extending the maturity date to October 1, 2019. Further, the Company and the lender agreed that the customer’s minimum monthly royalty payments of $1,500 would be applied to reduce the principal and interest of the note. Total accounts receivable from the noteholder of $18,000 was applied to the note during the six months ended June 30, 2019. At June 30, 2019, the remaining balance of the note was $10,090. c) On April 8, 2019, the Company entered into a promissory bank loan with a non-related party for $52,063 of which $9,563 was the loan fee or original issue discount resulting in cash proceeds to the Company of $42,500. The note is due on April 8, 2020 and results in an annual percentage rate of 41.38%. d) On June 20, 2019 the Company entered into a promissory note with a non-related party for $40,000. The note is due December 31, 2019, is unsecured and bears an interest rate of 8% per annum. e) On June 21, 2019, the Company entered into a promissory bank loan with a non-related party for $6,741 of which $641 was the loan fee or original issue discount resulting in cash proceeds to the Company of $6,100. The note is due on April 8, 2020 and results in an annual percentage rate of 41.38%. The following table summarizes notes payable, related parties as of June 30, 2019 and December 31, 2018: Type Amount Origination Date Maturity Date Annual Interest Rate Balance at June 30, 2019 Balance at December 31, 2018 Note Payable, RP *** $ 30,000 4/10/2018 1/15/2019 3.00 % $ 30,000 $ 30,000 Note Payable, RP $ 380,000 6/20/2018 1/2/2020 8.00 % $ 380,000 $ 380,000 Note Payable, RP $ 350,000 6/20/2018 1/2/2020 5.00 % $ 339,000 $ 350,000 Note Payable, RP $ 17,000 6/20/2018 1/2/2020 5.00 % $ 17,000 $ 17,000 Note Payable, RP *** $ 50,000 7/27/2018 11/30/2018 8.00 % $ 50,000 $ 50,000 Note Payable, RP $ 5,000 10/9/2018 Demand 0.00 % $ 5,000 $ 5,000 Note Payable, RP $ 5,000 10/19/2018 Demand 0.00 % $ 5,000 $ 5,000 Note Payable, RP ** $ 3,000 10/24/2018 Demand 0.00 % $ — $ 3,000 Note Payable, RP (f)** $ 2,544 1/3/2019 6/30/2019 3.00 % $ — $ — Subtotal $ 826,500 $ 840,000 Debt Discount $ (6,637 ) $ (13,174 ) Balance, net $ 819,863 $ 826,826 Less current portion $ (819,863 ) $ (93,000 ) Total long-term $ — $ 733,826 ** Paid off during the period f) On January 3, 2019, the Company entered into a promissory note with the Chairman and President of the Company for $2,544. The note is due June 30, 2019, is unsecured and bears an interest rate of 3.0% per annum. At June 30, 2019, the remaining balance of this note was $0. The following table summarizes convertible notes payable as of June 30, 2019 and December 31, 2018: Type Amount Origination Date Maturity Date Annual Interest Rate Balance at March 31, 2019 Balance at December 31, 2018 Convertible Note Payable (g) $ 450,000 3/28/2018 3/31/2021 8.00 % $ — $ 450,000 Convertible Note Payable ** $ 38,000 7/30/2018 7/25/2019 12.00 % $ — $ 38,000 Convertible Note Payable ** $ 53,000 8/29/2018 8/27/2019 12.00 % $ — $ 53,000 Convertible Note Payable (h) * $ 50,000 12/6/2018 12/6/2019 5.00 % $ 36,123 $ 50,000 Convertible Note Payable (i) * $ 65,000 12/6/2018 12/6/2019 5.00 % $ 43,599 $ 65,000 Convertible Note Payable(j) *** $ 63,000 12/12/2018 12/5/2019 22.00 % $ 42,800 $ 63,000 Convertible Note Payable (g) $ 539,936 1/15/2019 1/15/2020 8.00 % — — Convertible Note Payable (k) *** $ 33,000 1/16/2019 1/15/2020 22.00 % $ 49,500 $ — Convertible Note Payable (l) $ 100,000 1/18/2019 1/16/2020 8.00 % $ 100,000 $ — Convertible Note Payable (m) $ 60,000 1/29/2019 1/22/2020 8.00 % $ 60,000 $ — Convertible Note Payable (n) * $ 50,000 2/1/2019 10/22/2019 12.00 % $ 50,000 $ — Convertible Note Payable (o) * $ 60,000 2/21/2019 2/14/2022 0.00 % $ 60,000 $ — Convertible Note Payable (p) $ 55,125 2/21/2019 2/20/2020 8.00 % $ 55,125 $ — Convertible Note Payable (q) *** $ 53,000 2/26/2019 2/20/2020 22.00 % $ 79,500 $ — Convertible Note Payable (r) $ 75,000 3/18/2019 12/13/2019 12.00 % $ 75,000 $ — Convertible Note Payable (s) *** $ 38,000 5/2/2019 4/29/2020 22.00 % 57,000 Subtotal $ 708,647 $ 719,000 Debt Discount $ (212,597 ) $ (165,186 ) Balance, net $ 496,050 $ 553,814 Less current portion $ (488,141 ) $ (161,280 ) Total long-term $ 7,909 $ 392,534 * Embedded conversion feature accounted for as a derivative liability g) On January 15, 2019, the Company executed a new, consolidated convertible note with a non-related party by extinguishing the March 28, 2018 convertible note in the amount of $450,000 with interest due of $28,898 and a $60,000 term note, dated October 31, 2018 with interest due of $1,038. The new convertible note is in the amount of $539,936, is due on or before January 15, 2022, has an 8% per annum interest rate and may be converted into shares of the Company’s common stock at $0.20 per share. The new note incorporates an anti-dilution feature if the Company issues more than 60,000,000 shares of its common stock. The embedded conversion option qualified for derivative accounting and bifurcation under ASC 815-15 Derivatives and Hedging. The initial fair value of the conversion feature was $292,651. The company recorded a loss on extinguishment of debt of $350,117 equal to the initial fair value of derivative liability on the new note and the previous unamortized debt discount balance of one the old notes. On March 27, 2019, the Company agreed to convert $548,686 of principal ($539,936) and interest ($8,750) of its convertible note payable into 3,597,989 shares of the Company’s common stock. The company recorded a gain on settlement of debt of $359,857 equal to the difference between both the fair value of the common shares of $523,867 and the fair value of the conversion feature at conversion of $335,038 compared to the carrying value of the note and interest. h) During the six months ended June 30, 2019, $14,877 of principal ($13,877) and interest ($1,000) of the convertible note payable was converted into 9,355,000 shares of the Company’s common stock. i) During the six months ended June 30, 2019, $23,401 of principal ($21,401) and interest ($2,000) of the convertible note payable was converted into 9,040,000 shares of the Company’s common stock. j) In the prior year, on December 12, 2018, the Company entered into a convertible promissory with a non-related party for $63,000 of which $3,000 was an original issue discount resulting in cash proceeds to the Company of $60,000. The note is due on December 5, 2019 and bears interest on the unpaid principal balance at a rate of 12% per annum. Any part of the note which is not paid when due shall bear interest at the rate of 22% per annum from the due date until paid. The Note may be converted by the Lender at any time after 180 days (June 10, 2019) of the date of issuance into shares of Company’s common stock at a conversion price equal to 61% of the average 3 lowest trading prices during the 15-trading day period prior to the conversion date. One June 10, 2019, the embedded conversion option qualified for derivative accounting and bifurcation under ASC 815-15 Derivatives and Hedging. The initial fair value of the conversion feature was $142,265 and resulted in a discount to the note payable of $60,000 and an initial derivative expense of $82,265. On June 19, 2019, the Company defaulted on the note, resulting in a default penalty of $25,500 added to the principal of the note and the remaining discount was accelerated and recognized to interest expense. During the six months ended June 30, 2019, $45,700 of the convertible note payable was converted into 7,946,913 shares of the Company’s common stock. k) On January 16, 2019, the Company entered into a convertible promissory with a non-related for $33,000 of which $3,000 was an original issue discount resulting in cash proceeds to the Company of $30,000. The note is due on January 15, 2020 and bears interest on the unpaid principal balance at a rate of 12% per annum. Stringent pre-payment terms apply (from 12% to 37%, dependent upon the timeframe of repayment during the note’s term) and any part of the note which is not paid when due shall bear interest at the rate of 22% per annum from the due date until paid. The Note may be converted by the Lender at any time after 180 days of the date of issuance into shares of Company’s common stock at a conversion price equal to 61% of the lowest trading price during the 15-trading day period prior to the conversion date. On June 19, 2019, the Company defaulted on the note, resulting in the note becoming immediately convertible and a default penalty of $16,500 added to the principal of the note. On June 19, 2019, the embedded conversion option qualified for derivative accounting and bifurcation under ASC 815-15 Derivatives and Hedging. The initial fair value of the conversion feature was $116,540 and resulted in a discount to the note payable of $30,000 and an initial derivative expense of $86,540. Due to the note being in default, the remaining discount was accelerated and recognized to interest expense. l) On January 18, 2019, the Company entered into a convertible promissory note with a non-related party for $100,000 of which $5,000 was an original issue discount and $5,000 was paid directly to third parties resulting in cash proceeds to the Company of $90,000. The note is due on January 16, 2020 and bears interest on the unpaid principal balance at a rate of 8% per annum. Stringent pre-payment terms apply (from 10% to 30%, dependent upon the timeframe of repayment during the note’s term) and any part of the note which is not paid when due shall bear interest at the rate of 24% per annum from the due date until paid. The Note may be converted by the Lender at any time after 180 days of the date of issuance into shares of Company’s common stock at a conversion price equal to 64% of the average 2 lowest trading prices during the 10-trading day period prior to the conversion date. Due to this provision, the Company considered whether the embedded conversion option qualifies for derivative accounting and bifurcation under ASC 815-15 Derivatives and Hedging. The note isn’t convertible until 180 days following funding and no derivative liability was recognized as of June 30, 2019. m) On January 29, 2019, the Company entered into a convertible promissory note with a non-related for $60,000 of which $3,000 was an original issue discount and $8,000 was paid directly to third parties resulting in cash proceeds to the Company of $49,000. The note is due on January 22, 2020 and bears interest on the unpaid principal balance at a rate of 8% per annum. Stringent pre-payment terms apply (from 10% to 30%, dependent upon the timeframe of repayment during the note’s term) and any part of the note which is not paid when due shall bear interest at the rate of 18% per annum from the due date until paid. The Note may be converted by the Lender at any time after 180 days of the date of issuance into shares of Company’s common stock at a conversion price equal to the lower of 64% of the average 2 lowest trading prices during the 10-trading day period prior to the conversion date or $0.12. Due to this provision, the Company considered whether the embedded conversion option qualifies for derivative accounting and bifurcation under ASC 815-15 Derivatives and Hedging. The note isn’t convertible until 180 days following funding and no derivative liability was recognized as of June 30, 2019. n) On February 1, 2019, the Company entered into a convertible promissory note with a non-related party for $50,000 of which $5,000 was an original issue discount resulting in cash proceeds to the Company of $45,000. The note is due on October 22, 2019 and bears interest on the unpaid principal balance at a rate of 12% per annum and a default interest rate of 24% per annum. The Note may be converted by the Lender at any time after the date of issuance into shares of Company’s common stock at a conversion price equal 50% of the lowest trading price during the 20-trading day period prior to the conversion date. As the closing sales price fell below $0.03, an additional 15% discount was be attributed to the conversion price. The embedded conversion option qualified for derivative accounting and bifurcation under ASC 815-15 Derivatives and Hedging. The initial fair value of the conversion feature was $158,142 and resulted in a discount to the note payable of $50,000 and an initial derivative expense of $113,142. During the period ended June 30, 2019, the Company recorded accretion of $18,326 increasing the carrying value of the note to $18,326. o) On February 21, 2019, the Company entered into a convertible promissory note with a non-related party for $60,000 of which $5,000 was an original issue discount and $8,000 was paid directly to third parties resulting in cash proceeds to the Company of $47,000. The Company also issued a warrant with a term of five years to purchase up to 300,000 shares of common stock of the Company at an exercise price of $0.20 per share and subject to adjustment for dilutive issuances and cashless exercise. The note is due on February 14, 2022 and bears interest on the unpaid principal balance at a rate of 0% per annum. Stringent pre-payment terms apply (from 10% to 40%, dependent upon the timeframe of repayment during the note’s term) and in the event of default an additional 40% of the principal and interest balance shall be owed. The Note may be converted by the Lender at any time after the date of issuance into shares of Company’s common stock at a conversion price equal to the lower of 60% of the lowest trading price during the 20-trading day period prior to the conversion date or $0.12. If at any time the closing sales price falls below $0.01, then an additional 10% discount will be attributed to the conversion price. The embedded conversion option and warrant qualified for derivative accounting and bifurcation under ASC 815-15 Derivatives and Hedging. The initial fair value of the conversion feature of $124,796 and the warrant of $51,856 resulted in a discount to the note payable of $60,000 and an initial derivative expense of $129,652. During the period ended June 30, 2019, the Company recorded accretion of $7,909 increasing the carrying value of the note to $7,909. p) On February 21, 2019, the Company entered into a convertible promissory note with a non-related party for $55,125 of which $2,500 was an original issue discount and $2,625 was paid directly to third parties resulting in cash proceeds to the Company of $50,000. The note is due on February 20, 2020 and bears interest on the unpaid principal balance at a rate of 8% per annum. Stringent pre-payment terms apply (from 10% to 30%, dependent upon the timeframe of repayment during the note’s term) and any part of the note which is not paid when due shall bear interest at the rate of 24% per annum from the due date until paid. The Note may be converted by the Lender at any time after 180 days of the date of issuance into shares of Company’s common stock at a conversion price equal to 64% of the average 2 lowest trading prices during the 10-trading day period prior to the conversion date. Due to this provision, the Company considered whether the embedded conversion option qualifies for derivative accounting under ASC 815-15 Derivatives and Hedging. The note isn’t convertible until 180 days following funding and no derivative liability was recognized as of June 30, 2019. q) On February 26, 2019, the Company entered into a convertible promissory with a non-related for $53,000 of which $3,000 was an original issue discount resulting in cash proceeds to the Company of $50,000. The note is due on February 20, 2020 and bears interest on the unpaid principal balance at a rate of 12% per annum. Stringent pre-payment terms apply (from 12% to 37%, dependent upon the timeframe of repayment during the note’s term) and any part of the note which is not paid when due shall bear interest at the rate of 22% per annum from the due date until paid. The Note may be converted by the Lender at any time after 180 days of the date of issuance into shares of Company’s common stock at a conversion price equal to 61% of the lowest trading price during the 15-trading day period prior to the conversion date. On June 19, 2019, the Company defaulted on the note, resulting in the note becoming immediately convertible and a default penalty of $26,500 added to the principal of the note. On June 19, 2019, the embedded conversion option qualified for derivative accounting and bifurcation under ASC 815-15 Derivatives and Hedging. The initial fair value of the conversion feature was $187,924 and resulted in a discount to the note payable of $50,000 and an initial derivative expense of $137,924. Due to the note being in default, the remaining discount was accelerated and recognized to interest expense. r) On March 18, 2019, the Company entered into a convertible promissory note with a non-related party for $75,000 of which $10,250 was an original issue discount resulting in cash proceeds to the Company of $64,750. The Company also issued a warrant with a term of five years to purchase up to 187,500 shares of common stock of the Company at an exercise price of $0.20 per share and subject to adjustment for dilutive issuances and cashless exercise. The note is due on December 13, 2019 and bears interest on the unpaid principal balance at a rate of 12% per annum and a default interest rate of 24% per annum. The Note may be converted by the Lender at any time after the date of issuance into shares of Company’s common stock at a conversion price equal to 50% of the lowest trading price during the 25-trading day period prior to the conversion date. The embedded conversion option and warrant qualified for derivative accounting and bifurcation under ASC 815-15 Derivatives and Hedging. The initial fair value of the conversion feature of $139,196 and the warrant of $25,401 resulted in a discount to the note payable of $75,000 and an initial derivative expense of $99,847. During the period ended June 30, 2019, the Company recorded accretion of $18,430 increasing the carrying value of the note to $18,430. s) On May 2, 2019, the Company entered into a convertible promissory with a non-related for $38,000 of which $3,000 was an original issue discount resulting in cash proceeds to the Company of $35,000. The note is due on April 29, 2020 and bears interest on the unpaid principal balance at a rate of 12% per annum. Stringent pre-payment terms apply (from 12% to 37%, dependent upon the timeframe of repayment during the note’s term) and any part of the note which is not paid when due shall bear interest at the rate of 22% per annum from the due date until paid. The Note may be converted by the Lender at any time after 180 days of the date of issuance into shares of Company’s common stock at a conversion price equal to 61% of the lowest trading price during the 15-trading day period prior to the conversion date. On June 19, 2019, the Company defaulted on the note, resulting in the note becoming immediately convertible and a default penalty of $19,000 added to the principal of the note. On June 19, 2019, the embedded conversion option qualified for derivative accounting and bifurcation under ASC 815-15 Derivatives and Hedging. The initial fair value of the conversion feature was $135,455 and resulted in a discount to the note payable of $35,000 and an initial derivative expense of $100,455. Due to the note being in default, the remaining discount was accelerated and recognized to interest expense.

DERIVATIVE AND PREFERRED STOCK

DERIVATIVE AND PREFERRED STOCK LIABILITIES	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
DERIVATIVE AND PREFERRED STOCK LIABILITIES	NOTE 7 – DERIVATIVE AND PREFERRED SERIES A STOCK LIABILITIES The embedded conversion option of (1) the convertible debentures described in Note 6; (2) preferred series A stock liability; (3) warrants; contain conversion features that qualify for embedded derivative classification. The fair value of the liabilities will be re-measured at the end of every reporting period and the change in fair value will be reported in the statement of operations as a gain or loss on derivative financial instruments. Upon the issuance of the convertible notes payable described in Note 6, the Company concluded that it only has sufficient shares to satisfy the conversion of some but not all of the outstanding convertible notes, warrants and options. The Company elected to reclassify contracts from equity with the earliest inception date first. As a result, none of the Company’s previously outstanding convertible instruments qualified for derivative reclassification, however, any convertible securities issued after the election, including the warrants described in Note 10, qualified for derivative classification. The Company reassesses the classification of the instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. The table below sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities. June 30, 2019 December 31, 2018 Balance at the beginning of period $ 322,976 $ — Original discount limited to proceeds of notes 331,750 100,000 Fair value of derivative liabilities in excess of notes proceeds received 749,825 247,033 Settlement of derivative instruments (257,268 ) — Change in fair value of embedded conversion option 2,201,816 (24,057 ) Balance at the end of the period $ 3,349,099 $ 322,976 The Company uses Level 3 inputs for its valuation methodology for the embedded conversion option and warrant liabilities as their fair values were determined by using the Binomial Model based on various assumptions. Significant changes in any of these inputs in isolation would result in a significant change in the fair value measurement. As required, these are classified based on the lowest level of input that is significant to the fair value measurement. The following table shows the assumptions used in the calculations: Expected Volatility Risk-free Interest Rate Expected Dividend Yield Expected Life (in years) At issuance 128-301% 2.11-2.51% 0 % 0.49-5.00 At June 30, 2019 160-336% 1.71-2.23% 0 % 0.32-4.71 On December 1, 2018, the Company’s Board of Director authorized an offering for 1,000,000 Preferred Series “A” stock at $0.10 per share and with 100%, regular or cashless exercise at $0.10 per share of common stock warrant coverage. At December 31, 2018, the Company received $60,000 of subscriptions for the issuance of 600,000 shares of Preferred Series “A” stock to three accredited investors who are related parties. On December 1, 2018, the Company issued 600,000 warrants subject to cashless exercise at $0.10 per share for 5 years. The Company was unable to issue the subscriber the preferred shares until the Company filed a Certificate of Designation and the Preferred Series “A” stock had been duly validly authorized. As the Company had not filed the Certificate of Designation, and as the Company could not issue the preferred shares to settle the proceeds received, it was determined the subscriptions were settleable in cash. As a result, the Company classified the subscriptions received as a liability in accordance with ASC 480 Distinguishing Liabilities from Equity. The fair value of the liability of the preferred series A stock at December 31, 2018 was $144,352. On March 29, 2019, the Company executed a settlement agreement that included the settlement of 100,000 of the Series A Preferred Shares and 100,000 of the warrants subscribed for as part of the December 1, 2018 offering. The Company agreed to issue 164,000 shares of its common stock as payment in full $25,000 owed to the subscriber for services rendered; the Company agreed to accept conversion and exercise of the purchased 100,000 Preferred Series A shares into 100,000 shares of the Company’s common stock and the Company shall accept the cashless conversion of 100,000 warrant into 34,400 shares of the Company’s restricted common stock; and, as inducement for and consideration for the settlement of the Company’s debt, the Company agrees to grant 500,000 additional shares of the Company’s restricted stock. The Company recorded the fair value of the shares issued of $103,792 and recorded a loss on the settlement of the subscriptions and the amounts payable of $55,830. On April 12, 2019, the Company filed the Certificate of Designation for the Series A Convertible Preferred Stock. The fair value of the liability of the preferred series A stock on April 12, 2019 was $60,398. On April 12, 2019, the Company adjusted the fair value of the preferred series A stock to $60,398 and reclassified the fair value of the preferred series A stock to mezzanine equity. The Company uses Level 3 inputs for its valuation methodology for the preferred series A stock liability as their fair values were determined by using the Binomial Model based on various assumptions. Significant changes in any of these inputs in isolation would result in a significant change in the fair value measurement. As required, these are classified based on the lowest level of input that is significant to the fair value measurement. The following table shows the assumptions used in the calculations: Expected Volatility Risk-free Interest Rate Expected Dividend Yield Expected Life (in years) At April 12, 2019 170% 2.36% 0 % 3.00

STOCKHOLDERS' DEFICIT AND STOCK

STOCKHOLDERS' DEFICIT AND STOCK OPTIONS	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
STOCKHOLDERS' DEFICIT AND STOCK OPTIONS	NOTE 8 - STOCKHOLDERS’ DEFICIT Preferred Stock Effective March 23, 2018, the Company amended the articles of incorporation and authorized 10,000,000 shares of preferred stock with a par value of $0.001 per share; of which 1,000,000 shares were designated as Series A Convertible Preferred Stock as of June 30, 2019. The preferred stock may be issued from time to time by the board of directors as shares of one or more classes or series. On December 1, 2018, the Company’s Board of Director authorized an offering for 1,000,000 Preferred Series “A” stock at $0.10 per share and with 100%, regular or cashless exercise at $0.10 per share of common stock warrant coverage. At December 31, 2018, the Company received $60,000 of subscriptions for the issuance of 600,000 shares of Preferred Series “A” stock to three accredited investors who are related parties. The Company was unable to issue the subscriber the preferred shares until the Company filed a Certificate of Designation and the Preferred Series “A” stock has been duly validly authorized. See Note 7 for liabilities related to the Company’s commitment to issue shares of Series A stock upon the designation. On April 12, 2019, the Company filed a Certificate of Designation with the Nevada Secretary of State designating 1,000,000 shares of its authorized preferred stock as Series A Convertible Preferred Stock. The principal terms of the Series A Preferred Shares are as follows: Issue Price The stated price for the Series A Preferred shall be $0.10 per share. Redemption This Company may at any time following the first anniversary date of issuance (the “Redemption Date”), at the option of the Board of Directors, redeem in whole or in part the Shares by paying in cash in exchange for the Shares to be redeemed a price equal to the Original Series A Issue Price ($0.10) (the “Redemption Price”). Any redemption affected pursuant to this provision shall be made on a pro rata basis among the holders of the Shares in proportion to the number of Shares then held by them. Dividends None. Preference of Liquidation In the event of any liquidation, dissolution or winding up of the Company, the holders of Shares shall be entitled to receive, prior and in preference to any distribution of any of the assets of this Company to the holders of Common Stock by reason of their ownership thereof, an amount per share equal to the sum of (i) $0.10 for each outstanding Share (the “Original Series A Issue Price”) and (ii) an amount equal to 6% of the Original Series A Issue Price for each 12 months that has passed since the date of issuance of any Shares (such amount being referred to herein as the “Premium”). For purposes of this provision, a liquidation, dissolution or winding up of this Company shall be deemed to be occasioned by, or to include, (A) the acquisition of the Company by another entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation but, excluding any merger effected exclusively for the purpose of changing the domicile of the Company); or (B) a sale of all or substantially all of the assets of the Company; unless the Company’s stockholders of record as constituted immediately prior to such acquisition or sale will, immediately after such acquisition or sale (by virtue of securities issued as consideration for the Company’s acquisition or sale or otherwise) hold at least 50% of the voting power of the surviving or acquiring entity. If upon the occurrence of such liquidation, dissolution or winding up event, the assets and funds thus distributed among the holders of the Shares shall be insufficient to permit the payment to such holders of the full aforesaid preferential amounts, then, subject to the rights of series of preferred stock that may from time to time come into existence, the entire assets and funds of the Company legally available for distribution shall be distributed ratably among the holders of the Shares in proportion to the preferential amount each such holder is otherwise entitled to receive. In any of such liquidation, dissolution or winding up event, if the consideration received by the Company is other than cash, its value will be deemed its fair market value. Any securities shall be valued as follows: A. Securities not subject to investment letter or other similar restrictions on free marketability (covered by (B) below): 1) If traded on a securities exchange (NASDAQ, AMEX, NYSE, etc.), the value shall be deemed to be the average of the closing prices of the securities on such exchange over the thirty day period ending three (3) days prior to the closing; 2) If traded on a quotation system, such as the OTC:QX, OTC:QB or OTC Pink Sheets, the value shall be deemed to be the average of the closing bid or sale prices (whichever is applicable) over the thirty day period ending three (3) days prior to the closing; and 3) If there is no active public market, the value shall be the fair market value thereof, as mutually determined by the Company and the holders of at least a majority of the voting power of all then outstanding shares of Preferred Stock. B. The method of valuation of securities subject to investment letter or other restrictions on free marketability (other than restrictions arising solely by virtue of a stockholder’s status as an affiliate or former affiliate) shall be to make an appropriate discount from the market value determined as above in (A) (1), (2) or (3) to reflect the approximate fair market value thereof, as mutually determined by the Company and the holders of at least a majority of the voting power of all then outstanding shares of such Preferred Stock. Voting The holder of each Share shall not have any voting rights, except in the case of voting on a change in the preferences of Shares. Conversion Each Share shall be convertible into shares of the Company’s Common Stock at a price per share of $0.10 (1 Share converts into 1 share of Common Stock), at the option of the holder thereof, at any time following the date of issuance of such Share and on or prior to the fifth day prior to the Redemption Date, if any, as may have been fixed in any Redemption Notice with respect to the Shares, at the office of this Company or any transfer agent for such stock. Each Share shall automatically be converted into shares of Common Stock on the first day of the thirty-sixth (36th) month following the original issue date of the Shares, at the Conversion Price per share. The Company was unable to issue the subscribers the preferred shares until the Company filed a Certificate of Designation and the Preferred Series “A” stock had been duly validly authorized. As the Company had not filed the Certificate of Designation, and as the Company could not issue the preferred shares to settle the proceeds received, it was determined the subscriptions were settleable in cash. As a result, the Company classified the subscriptions received as a liability in accordance with ASC 480 Distinguishing Liabilities from Equity. The filing of the Certificate of Designation and issuance of the preferred shares resulted in the reclassification of the Series A Preferred Shares from a liability to temporary equity or “mezzanine” because the preferred shares include the liquidation preferences described above. The fair value of the preferred series A stock on April 12, 2019 was $60,398 and was valued by using the Binomial Model based on various assumptions. As of June 30, 2019, there were 500,000 shares of Series A Convertible Preferred Stock issued or outstanding. Common Stock Effective March 23, 2018, the Company amended the articles of incorporation and increased the authorized shares of common stock with a par value of $0.001 per share from 100,000,000 to 300,000,000 shares. The number of shares outstanding of the registrant’s common stock as of June 30, 2019 was 76,859,961. On January 1, 2019, the Company entered into a four-year employment agreement with F. Jody Read in his role as Chief Executive Officer. The terms of the contract call for an annual salary of $90,000 for the first year, effective March 1, 2019 and increasing to $120,000 once the Company’s revenue exceeds monthly expenses, then incrementally over time and with certain operational results, up to $200,000/year. The salary may be paid, at the employee’s discretion, either in cash or in common stock. A $1,000 per month allowance will be granted to the executive for housing near the Company’s South Carolina facility. The employment agreement awards the CEO 1,500,000 restricted shares of the Company’s restricted stock, which shall vest in the following manner: 375,000 shares on March 1, 2019, 375,000 shares on March 1, 2020; 375,000 shares on March 1, 2021 and the final 375,000 shares on March 1, 2022. On January 1, 2019 the fair value of the restricted stock award totaled $240,000 which will be expensed over vesting period. As of June 30, 2019, 375,000 shares were issued and the Company had recognized $88,052 of expense. On January 28, 2019, the Company agreed to convert $131,327 of principal and interest of the notes payable described in Note 6(a) into 987,421 shares of the Company’s common stock. On March 25, 2019, the Company issued 200,000 shares of common stock to two employees of the Company as compensation in lieu of commission on sales of the Company’s products. The Company recorded the fair value of the common shares of $34,000 in consulting expense. On March 29, 2019, the Company executed a settlement agreement with a contractual consultant, UCAP Partners, LLC for the settlement of $25,000 owed to the contractor for the provision of services as related to the March 15, 2018 agreement between UCAP and us. The settlement terms include acknowledgement that the Company owes UCAP $25,000 as payment for said services; that UCAP purchased and fully paid for Series A Preferred Stock and Warrants from the Company on December 3, 2018 (100,000 Preferred Series A Shares and 100,000 warrants to purchase common shares at $0.10/share); the settlement is outlined as follows: the Company shall issue 164,000 shares of its common stock as payment in full for the services rendered on the consulting contract; the Company shall accept UCAP’s conversion and exercise of the purchased 100,000 Preferred Series A shares into 100,000 shares of the Company’s common stock and the Company shall accept the cashless conversion of UCAP’s 100,000 warrant into 34,400 shares of the Company’s restricted common stock; and, as inducement for and consideration for the settlement of the Company’s debt to UCAP, the Company agrees to grant 500,000 additional shares of the Company’s restricted stock. As a result of this transaction, 3,597,989 shares of Company’s common stock were issued and a $55,830 loss on settlement of debt was recognized. From June 11, 2019 to June 27, 2019, the Company issued a total of 9,040,000 shares of common stock upon the conversion of $23,401 of principal ($21,401) and interest ($2,000) pursuant to the convertible note payable described in Note 6(i). From June 12, 2019 to June 27, 2019, the Company issued a total of 9,355,000 shares of common stock upon the conversion of $14,877 of principal ($13,877) and interest ($1,000) pursuant to the convertible note payable described in Note 6(h). From June 19, 2019 to June 27, 2019, the Company issued a total of 7,946,913 shares of common stock upon the conversion of $45,700 of principal pursuant to the convertible note payable described in Note 6(j). NOTE 9 – STOCK OPTIONS The Company did not grant any stock options during the year ended December 31, 2018 or the six months ended June 30, 2019. Below is a table summarizing the options issued and outstanding as of June 30, 2019: Number of Weighted average exercise price Balance, December 31, 2018 2,287,500 0.34 Granted — — Expired (1,905,000 ) 0.16 Settled — — Balance, June 30, 2019 382,500 1.24 As at June 30, 2019, the following share stock options were outstanding: Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 01/01/2016 75,000 75,000 0.33 0.50 12/31/2019 25,000 01/01/2016 90,000 90,000 0.33 0.50 12/31/2019 30,000 09/15/2016 10,000 10,000 1.00 0.50 12/31/2019 10,000 10/01/2016 7,500 7,500 1.00 0.50 12/31/2019 7,500 01/26/2017 200,000 200,000 2.00 2.58 01/26/2022 400,000 382,500 382,500 $ 472,500 The weighted average exercise prices are $1.24 for the options outstanding and exercisable, respectively. The intrinsic value of stock options outstanding at June 30, 2019 was $Nil.

WARRANTS

WARRANTS	6 Months Ended
	Jun. 30, 2019
Guarantees and Product Warranties [Abstract]
WARRANTS	NOTE 10 – WARRANTS As described in Note 6, on from February 14 through March 13, 2019, the Company issued 487,500 warrants subject to an exercise price of $0.20 per share for 5 years. If the Company issues any common stock or common stock equivalents at an effective price per share less than the warrant’s exercise price of $0.20, the exercise price of the warrants will be reduced to the lower price. In addition, the number of common shares issuable upon conversion of the warrants is increased so that the number of shares issuable multiplied by the exercise price equals the aggregate exercise price of the warrants immediately prior to the exercise reduction. During period, convertible notes were exercised at a price less than the original exercise price of these warrants, resulting in an adjustment to the number of warrants and exercise price. The Company concluded that it only has sufficient shares to satisfy the conversion of some but not all of the outstanding convertible instruments. The initial fair value of the warrants issued during the period was calculated using the Binomial Model as described in Note 7. The following table summarizes the continuity of share purchase warrants: Number of Weighted average exercise price Balance, December 31, 2018 650,000 0.17 Adjustment to warrants outstanding 420,891,071 0.00035 Granted 487,500 0.20 Settled (100,000 ) 0.10 Balance, June 30, 2019 421,928,571 0.00047 As at June 30, 2019, the following share purchase warrants were outstanding: Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 11/28/2018 142,857,143 * 142,857,143 * 0.00035 * 2.42 11/28/2021 $ 50,000 12/3/2018 500,000 500,000 0.10 4.43 12/3/2023 50,000 2/14/2018 171,428,571 * 171,428,571 * 0.00035 * 4.63 2/14/2024 60,000 3/13/2018 107,142,857 * 107,142,857 * 0.00035 * 4.71 3/13/2024 37,500 421,928,571 421,928,571 $ 197,500 *The number of warrants outstanding and exercisable is variable based on adjustments to the exercise price of the warrant due to dilutive issuances. The intrinsic value of warrants outstanding at June 30, 2019 was $1,959,643.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2019
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 11 – RELATED PARTY TRANSACTIONS The Company has agreements with related parties for consulting services, accrued rent, accrued interest, notes payable and stock options. See Notes to Financial Statements numbers 6, 9, 8 and 12 for more details.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 12 – COMMITMENTS AND CONTINGENCIES Consulting Agreements On January 1, 2018, the Company entered into a contract for consulting services with a Florida-based agricultural advocacy group. The agreement included a $5,000 initial engagement fee and $1,250 per month through January 1, 2019. On March 15, 2018, the Company entered into a 12-month service agreement, expiring on March 15, 2019, for strategic planning, financing, capital formation, up listing and expansion of the Company’s shareholder base. The consulting company received a $5,000 non-refundable initial fee and the agreement included $2,500 per month through March 14, 2019 and received 2,000,000 shares of the Company’s restricted common stock. On July 2, 2018, the Company entered into a 6-month service contract for investor relations services through January 2, 2019. The agreement called for 1,000,000 restricted shares of common stock to be issued to Life Sciences Journeys, Inc. The shares were issued on October 9, 2018. The Company placed a stop transfer order on the shares, discussed the benefits of services provided by Life Sciences Journeys and rescinded its stop transfer, allowing the contract to continue through its end. On November 28, 2018, the Company re-engaged the services of a prior contractor for finance assistance related to obtaining a line of credit based on the Company’s equipment and/or contracts, through November 27, 2019. If the Company obtains a line of credit based on the Company’s equipment and/or contracts the Company will incur a fee of 4% of financings from $1,000,000 to $5,000,000, 3% of financings from $5,000,001 to $10,000,000, and 0.25% of financings over $10,000,000. On December 3, 2018, the Company engaged a consultant for services related to business development in the healthcare market. The contract is in place through June 3, 2019 and the consultant received 100,000 restricted shares of the Company’s common stock for the services. In addition to contracts for service, the Company also regularly uses the professional services of securities attorneys, a US EPA specialist, professional accountants and other public-company specialists. Employment Agreements – On September 1, 2017, the Company entered into a five-year employment agreement with Marion E. Paris, Jr. to be the Vice President for Business Development and Director of Intellectual Properties for Paradigm. Under the terms of the employment agreement, Mr. Paris is to be paid an annual base salary of $90,000 and other benefits, including four weeks paid vacation. On January 1, 2019, the Company entered into a four-year employment agreement with F. Jody Read in his role as Chief Executive Officer. The terms of the contract call for an annual salary of $90,000 for the first year, effective March 1, 2019 and increasing to $120,000 once the Company’s revenue exceeds monthly expenses, then incrementally over time and with certain operation results, up to $200,000/year. The salary may be paid, at the employee’s discretion, either in cash or in common stock. A $1,000 per month allowance will be granted to the executive for housing near the Company’s South Carolina facility. The employment agreement awards the CEO 1,500,000 restricted shares of the Company’s restricted stock, which shall vest in the following manner: 375,000 shares on March 1, 2019, 375,000 shares on March 1, 2020, 375,000 shares on March 1, 2021 and the final 375,000 shares on March 1, 2022. Other Obligations and Commitments – On April 12, 2018, the Company entered into a Purchase agreement with a third party to purchase its exclusive rights to US EPA Product Registration No. 83241-1 for a fixed fee. The Company paid $5,000 on execution of the agreement and has continued to make periodic installment payments for the purchase of this Registration. On March 27, 2019, the Company entered into a letter of intent (the “LOI”) with Magnolia Columbia Limited (“Magnolia”), a Canadian company traded on the TSXV under the symbol “MCO”. Pursuant to the terms of the LOI, the parties agreed to negotiate and enter into a definitive agreement on or before April 27, 2019. As of April 28, 2019, we had not entered into a definitive agreement with Magnolia or agreed to any extensions of the LOI, therefore the LOI terminated.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 13. SUBSEQUENT EVENTS 2705908 Ontario Inc. On July 12, 2019, the Company entered into a binding Letter of Intent (“LOI”) to negotiate in good faith a transaction with 2705908 Ontario Inc. for a definitive loan and option agreement to include the acquisition of at least 51% control of the Company, in addition to the other terms and commitments. On July 30, 2019, the LOI due diligence and negotiations were slated to terminate, but both parties agreed to extend the term of the LOI through August 19, 2019. On August 19, 2019 the Company and 2705908 Ontario Inc. allowed the LOI to expire but continue discussions. On July 30, 2019, the Company accepted a settlement proposal from Annihilare, Inc. (a sub-registrant of the Company’s US EPA Registration No. 92108-1) and its affiliated company, Prime ITS (a prior owner of Annihilyzer Inc, which transferred previously noted intangible IT assets to PCT LTD for 2,250,000 shares of the Company’s common stock in November of 2016). The settlement agreement included credit to the Company by Prime ITS in the gross amount of $23,209 on the Company’s payable to Prime ITS for a combination of a portion of Marty Paris’ salary, a resignation from Marty Paris effective July 31, 2019, and equal valued amount of PCT’s inventory, for net credit to PCT in the amount of $13,939, which was received by the Company on July 31, 2019. The transaction was completed on August 1, 2019. On August 8, 2019, the Company received notice from PRIME ITS that certain technology services utilized by the Company shall cease to be provided, effective September 8, 2019. The Company will obtain competitive quotes from other technology services providers. On August 8, 2019, the Company received notice from Annihilare, Inc. that certain intellectual properties developed jointly between the Company and Annihilare are to be discontinued from use by the Company and its customers. The Company disputes the claims from Annihilare that the intellectual properties are exclusively Annihilare’s and are in discussions with Annihilare on this point. Until this issue is resolved, the impact to the Company is minimal because the Company’s healthcare customers primarily benefit from the disinfecting fluid solutions utilized by deploying the Company’s Annihilyzer Infection Control System, along with the Company-owned, patent-protected RFID disinfectant/material tracking system. The disputed issue is relative to a protocol software system, which is not a necessary feature of the Company’s Annihilyzer Infection Control System. The protocol software system is considered a complimentary feature and the Company expended employee time and expertise in its development. On August 12, 2019, the Company amended the Employment Contract with F. Jody Read, CEO, whereby 500,000 Preferred Series B shares will be issued to Read as soon as the Preferred Series B shares are designated with the State of Nevada. All other terms of the January 1, 2019 employment agreement remain in effect. On August 12, 2019, the Company entered into a four-year employment agreement with Gary, J. Grieco, its President, whereby Mr. Grieco will continue to receive $24,000 per year for services to Company as its President and whereby 500,000 Preferred Series B shares will be issued to Grieco as soon as the Preferred Series B shares are designated with the State of Nevada. The employment agreement begins on August 12, 2019, is automatically renewable for two years unless terminated earlier as per the terms of the agreement. Effective August 20, 2019, the Company filed a Certificate of Designation with the Nevada Secretary of State thereby designating 1,000,000 shares of its authorized preferred stock as Series B – Super Voting Convertible Preferred Stock. Holders of the Series B Preferred Stock are entitled to cast five hundred votes for each share held on all matters presented to stockholders for vote, which shall vote along with holders of the Company’s common stock. In addition, the Series B Preferred Stock shall be redeemed at par value by the Company upon the successful receipt by the Company of at least $1,000,000 in equity capital following the issuance of the Series B Preferred Stock. From July 1, 2019 through August 9, 2019, the Company issued a total of 157,924,689 shares of common stock upon the conversion of $113,847 of principal, $7,132 of interest and of fees pursuant to the convertible notes payable described in Note 6. On August 16, 2019, the Company issued 5,989,500 shares of common stock upon the cashless exercise of 6,000,000 warrants.

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
Nature of Operations	Nature of Operations PCT LTD (formerly Bingham Canyon Corporation, (the “Company,” “PCT Ltd,” or “Bingham”), a Delaware corporation, was formed on August 27, 1986. The Company changed its domicile to Nevada on August 26, 1999. On August 31, 2016, the Company entered into a Securities Exchange Agreement with Paradigm Convergence Technologies Corporation (“Paradigm”) to affect the acquisition of Paradigm as a wholly-owned subsidiary. Under the terms of the agreement, Bingham issued 16,790,625 restricted common shares of Bingham stock to the shareholders of Paradigm in exchange for all 22,387,500 outstanding common shares of Paradigm stock. In addition, Bingham issued options exercisable into 2,040,000 shares of the Bingham’s common stock (with exercise prices ranging between $0.133 and $0.333) in exchange for 2,720,000 outstanding Paradigm stock options (with exercise prices ranging between $0.10 and $0.25). These 2,040,000 options have been adjusted at the same exchange rate of 75% that the outstanding common shares were exchanged. As a result of this share exchange agreement, Paradigm, the operating company, is considered the accounting acquirer. Paradigm is located in Little River, SC and was formed June 6, 2012 under the name of EUR-ECA, Ltd. On September 11, 2015, its Board of Directors authorized EUR-ECA Ltd to file with the Nevada Secretary of State to change its name to Paradigm Convergence Technologies Corp. Paradigm is a technology licensing company specializing in environmentally safe solutions for global sustainability. The company holds a patent, intellectual property and/or distribution rights to innovative products and technologies. Paradigm provides innovative products and technologies for eliminating biocidal contamination from water supplies, industrial fluids, hard surfaces, food processing equipment, and medical devices. Paradigm’s overall strategy is to market new products and technologies through the use of equipment leasing, joint ventures, licensing, distributor agreements and partnerships. Effective on February 29, 2018, the Company changed its name from Bingham Canyon Corporation to PCT LTD to more accurately identify the Company’s direction and to develop the complimentary relationship and association with its wholly-owned operating company, Paradigm Convergence Technologies Corporation (“Paradigm” or “PCT Corp.”).
Principles of Consolidations	Principles of Consolidations The accompanying consolidated financial statements include the accounts of PCT LTD (“Parent”) and its wholly owned subsidiary, Paradigm Convergence Technologies Corporation (“Paradigm” or “Subsidiary”). All intercompany accounts have been eliminated upon consolidation.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingencies at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting periods. Estimates are based on historical experience and on various other market-specific and other relevant assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. The cash of $37,298 and $4,893 as of June 30, 2019 and December 31, 2018, respectively, represents cash on deposit in various bank accounts. There were no cash equivalents as of June 30, 2019 and December 31, 2018.
Fair Value Measurements	Fair Value Measurements The Company follows ASC 820, “Fair Value Measurements and Disclosures,” which defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. A fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last is considered unobservable, is used to measure fair value: • Level 1 - Valuations for assets and liabilities traded in active markets from readily available pricing sources such as quoted prices in active markets for identical assets or liabilities. • Level 2 - Observable inputs (other than Level 1 quoted prices) such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. • Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The carrying values of our financial instruments, including, cash and cash equivalents, accounts receivable, inventory, prepaid expenses, accounts payable and accrued expenses approximate their fair value due to the short maturities of these financial instruments. Derivative liabilities and preferred series A stock liabilities are determined based on “Level 3” inputs, which are significant and unobservable and have the lowest priority. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations. Our financial assets and liabilities carried at fair value measured on a recurring basis as of June 30, 2019, consisted of the following: Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Derivative liability (1) 3,349,099 — — 3,349,099 Total 3,349,099 — — 3,349,099 Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2018, consisted of the following: Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Preferred series A stock liability (1) 144,352 — — 144,352 Derivative liability (1) 322,976 — — 322,976 Total 467,328 — — 467,328 (1) The Company has estimated the fair value of these liabilities using the Binomial Model.
Derivative and Preferred Series A Stock Liabilities	Derivative and Preferred Series A Stock Liabilities The Company accounts for derivative instruments in accordance with ASC Topic 815, “ Derivatives and Hedging Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial statement. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. See Note 7 for additional information.
Accounts Receivable	Accounts Receivable Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. The Company provided allowances for uncollectible accounts receivable equal to the estimated collection losses that will be incurred in collection of all receivables. Accounts receivable is periodically evaluated for collectability bases on past credit history with customers and their current financial condition. The Company’s management determines which accounts are past due and if deemed uncollectible, the Company charges off the receivable in the period the determination is made. Based on management’s evaluation, the Company provided an allowance for doubtful accounts of $0 at June 30, 2019 and December 31, 2018, respectively.
Inventories	Inventories Inventories are stated at the lower of cost or market. Cost is determined by using the first in, first out (FIFO) method. We record the value of our inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand, future pricing and market conditions. As of June 30, 2019 and December 31, 2018, the inventory consisted of parts for equipment sold as replacement parts to existing customers or sold to new customers. The Company has recorded a reserve allowance of $0 and $0 as of June 30, 2019 and December 31, 2018, respectively. The Company has determined that some of the supplies inventory is necessary to be placed into service, after assembly into equipment to be used in product manufacturing and classified as Machinery and Equipment. The balance at June 30, 2019 and December 31, 2018 of such supplies and equipment not yet placed in service amounted to $306,225 and $319,735, respectively.
Property and Equipment	Property and Equipment Property and equipment are stated at purchased cost and depreciated utilizing a straight-line method over estimated useful lives ranging from 3 to 7 years after the asset has been placed in service. Upon selling equipment that had been under a lease agreement, the company discontinues the depreciation on that piece of equipment, as it transfers ownership to another entity. Additions and major improvements that extend the useful lives of property and equipment are capitalized. Maintenance and repairs are charged to operations as incurred. Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any related gains or losses are recorded in the results of operations.
Impairment of Long-lived Assets	Impairment of Long-lived Assets The carrying values of the Company’s long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the fair value. Under similar analysis no impairment was recorded during the six months ended June 30, 2019.
Intangible Assets	Intangible Assets Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology. Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 1 to 15 years. An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. The recorded impairment expense was nil for the six months ended June 30, 2019.
Research and Development	Research and Development Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.
Leases	Leases In February 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-02, Leases (Topic 842) ("ASC 842"), which requires lessees to recognize right-of-use ("ROU") assets and related lease liabilities on the balance sheet for all leases greater than one year in duration. We adopted ASC 842 on January 1, 2019 using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach did not require any transition accounting for leases that expired before the earliest comparative period presented. The adoption of this standard resulted in the recording of ROU assets and lease liabilities for our lease agreements with original terms of greater than one year. Upon implementation, the Company recognized an initial operating lease right-of-use asset of $43,330 and operating lease liability of $43,330. Due to the simplistic nature of the Company's leases, no retained earnings adjustment was required. See Note 5 for further details.
Revenue Recognition	Revenue Recognition On May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customer (Topic 606) The Company has the following three revenue streams: 1) product sales (equipment and/or fluid solutions); 2) licensing (contract-based use of the Company’s US EPA Product Registration, returning revenue in licensing fees and/or royalties from minimum or actual fluid sales); and 3) equipment leases (under systems service agreements, usually 3-year contracts for the provision of the Company’s equipment and service of such, under contract to customers, with renewable terms). The Company recognizes revenue from the sale of products when the performance obligation is satisfied by transferring control of the product to a customer. The Company recognizes revenue from the leasing of equipment as the entity provides the equipment and the customer simultaneously receives and consumes the benefits through the use of the equipment. This revenue generating activity would meet the criteria for a performance obligation satisfied over time. As a result, the Company recognizes revenue over time by using the output method, as the Company can measure progress of the performance obligation using the time elapsed under each obligation. The Company’s licenses provide a right to use and create performance obligations satisfied at a point in time. The Company recognizes revenue from licenses when the performance obligation is satisfied through the transfer of the license. For licenses that include royalties the Company will recognize royalty revenue as the underlying sales or usages occur, as long as this approach does not result in the acceleration of revenue ahead of the entity’s performance. The Company has disclosed disaggregated revenue via revenue stream on the face of the statement of operations. The Company did not have any contract assets or liabilities at June 30, 2019.
Basic and Diluted Loss per Share	Basic and Diluted Loss Per Share Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. As of June 30, 2019, there were outstanding common share equivalents (options, warrants, convertible debt and preferred series A stock) which amounted to 721,585,416 shares of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company has reviewed all other FASB issued ASU accounting pronouncements and interpretations thereof that have effective dates during the period reported and in future periods. The Company has carefully considered the new pronouncements that alter the previous GAAP and do not believe that any new or modified principles will have a material impact on the Company’s reported financial position or operations in the near term.

BASIS OF PRESENTATION AND SUM_3

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
Financial assets and liabilities carried at fair value measured on a recurring basis	Our financial assets and liabilities carried at fair value measured on a recurring basis as of June 30, 2019, consisted of the following: Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Derivative liability (1) 3,349,099 — — 3,349,099 Total 3,349,099 — — 3,349,099 Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2018, consisted of the following: Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Preferred series A stock liability (1) 144,352 — — 144,352 Derivative liability (1) 322,976 — — 322,976 Total 467,328 — — 467,328 (1) The Company has estimated the fair value of these liabilities using the Binomial Model.

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	6 Months Ended
	Jun. 30, 2019
Property, Plant and Equipment [Abstract]
Property and equipment	June 30, 2019 December 31, 2018 Machinery and leased equipment $ 151,719 $ 138,209 Machinery and equipment not yet in service 358,760 369,754 Office equipment and furniture 20,064 20,064 Website 2,760 2,760 Total property and equipment $ 533,303 $ 530,787 Less: Accumulated Depreciation (43,516 ) (30,815 ) Property and equipment, net 489,787 499,972

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	6 Months Ended
	Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Components of intangible assets	June 30, 2019 December 31, 2018 Patents $ 4,505,489 $ 4,514,989 Technology rights 200,000 235,500 Intangible, at cost 4,705,489 4,750,489 Less: Accumulated amortization (844,616 ) (690,714 ) Net Carrying Amount $ 3,860,873 $ 4,059,775
Estimated future amortization expense of intangible assets	$ For year ending December 31, 2019 155,168 For year ending December 31, 2020 303,613 For year ending December 31, 2021 302,003 For year ending December 31, 2022 302,003 For year ending December 31, 2023 to December 31, 2034 2,798,086 Total 3,860,873

LEASES (Tables)

LEASES (Tables)	6 Months Ended
	Jun. 30, 2019
Debt Disclosure [Abstract]
ROU assets and liabilities	June 30, 2019 Operating lease right-of-use asset $ 19,695 Operating lease liability: Current operating lease liability $ 21,704 Noncurrent operating lease liability — Total operating lease liability $ 21,704
Remaining lease payments	June 30, 2019 2019 - remaining $ 24,000 2020 and thereafter — Total lease payments 24,000 Less: imputed interest (2,296 ) Total ROU liabilities $ 21,704
Minimum payments under operating lease agreements	December 31, 2018 2019 $ 52,950 2020 — Total $ 52,950

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	6 Months Ended
	Jun. 30, 2019
Debt Disclosure [Abstract]
Notes payable	The following tables summarize notes payable as of June 30, 2019 and December 31, 2018: Type Amount Origination Date Maturity Date Annual Interest Rate Balance at June 30, 2019 Balance at December 31, 2018 Note Payable*** $ 150,000 5/18/2016 6/1/2019 19.00 % $ 150,000 $ 150,000 Note Payable *** $ 25,000 5/8/2017 6/30/2018 0.00 % $ 27,500 $ 27,500 Note Payable $ 130,000 6/20/2018 1/2/2020 8.00 % $ 130,000 $ 130,000 Note Payable (a) $ 126,964 6/20/2018 8/31/2018 6.00 % $ — $ 126,964 Note Payable (b) $ 26,500 6/26/2018 10/1/2019 10.00 % $ 10,090 $ 26,500 Note Payable (g) $ 60,000 10/30/2018 12/30/2018 8.00 % $ — $ 60,000 Note Payable *** $ 8,700 11/15/2018 6/30/2019 10.00 % $ 8,700 $ 8,700 Note Payable (c) $ 52,063 4/8/2020 4/8/2020 41.38 % $ 42,854 $ — Note Payable (d) $ 40,000 6/20/2019 12/31/2019 8.00 % $ 40,000 $ — Note Payable (e) $ 6,741 6/21/2019 4/8/2020 41.38 % $ 6,741 $ — Subtotal $ 415,885 $ 529,664 Debt Discount $ (9,579 ) $ (3,293 ) Balance, net $ 406,306 $ 526,371 Less current portion $ (406,306 ) $ (399,664 ) Total long-term $ — $ 126,707 *** Currently in default The following table summarizes notes payable, related parties as of June 30, 2019 and December 31, 2018: Type Amount Origination Date Maturity Date Annual Interest Rate Balance at June 30, 2019 Balance at December 31, 2018 Note Payable, RP *** $ 30,000 4/10/2018 1/15/2019 3.00 % $ 30,000 $ 30,000 Note Payable, RP $ 380,000 6/20/2018 1/2/2020 8.00 % $ 380,000 $ 380,000 Note Payable, RP $ 350,000 6/20/2018 1/2/2020 5.00 % $ 339,000 $ 350,000 Note Payable, RP $ 17,000 6/20/2018 1/2/2020 5.00 % $ 17,000 $ 17,000 Note Payable, RP *** $ 50,000 7/27/2018 11/30/2018 8.00 % $ 50,000 $ 50,000 Note Payable, RP $ 5,000 10/9/2018 Demand 0.00 % $ 5,000 $ 5,000 Note Payable, RP $ 5,000 10/19/2018 Demand 0.00 % $ 5,000 $ 5,000 Note Payable, RP ** $ 3,000 10/24/2018 Demand 0.00 % $ — $ 3,000 Note Payable, RP (f)** $ 2,544 1/3/2019 6/30/2019 3.00 % $ — $ — Subtotal $ 826,500 $ 840,000 Debt Discount $ (6,637 ) $ (13,174 ) Balance, net $ 819,863 $ 826,826 Less current portion $ (819,863 ) $ (93,000 ) Total long-term $ — $ 733,826 ** Paid off during the period The following table summarizes convertible notes payable as of June 30, 2019 and December 31, 2018: Type Amount Origination Date Maturity Date Annual Interest Rate Balance at March 31, 2019 Balance at December 31, 2018 Convertible Note Payable (g) $ 450,000 3/28/2018 3/31/2021 8.00 % $ — $ 450,000 Convertible Note Payable ** $ 38,000 7/30/2018 7/25/2019 12.00 % $ — $ 38,000 Convertible Note Payable ** $ 53,000 8/29/2018 8/27/2019 12.00 % $ — $ 53,000 Convertible Note Payable (h) * $ 50,000 12/6/2018 12/6/2019 5.00 % $ 36,123 $ 50,000 Convertible Note Payable (i) * $ 65,000 12/6/2018 12/6/2019 5.00 % $ 43,599 $ 65,000 Convertible Note Payable(j) *** $ 63,000 12/12/2018 12/5/2019 22.00 % $ 42,800 $ 63,000 Convertible Note Payable (g) $ 539,936 1/15/2019 1/15/2020 8.00 % — — Convertible Note Payable (k) *** $ 33,000 1/16/2019 1/15/2020 22.00 % $ 49,500 $ — Convertible Note Payable (l) $ 100,000 1/18/2019 1/16/2020 8.00 % $ 100,000 $ — Convertible Note Payable (m) $ 60,000 1/29/2019 1/22/2020 8.00 % $ 60,000 $ — Convertible Note Payable (n) * $ 50,000 2/1/2019 10/22/2019 12.00 % $ 50,000 $ — Convertible Note Payable (o) * $ 60,000 2/21/2019 2/14/2022 0.00 % $ 60,000 $ — Convertible Note Payable (p) $ 55,125 2/21/2019 2/20/2020 8.00 % $ 55,125 $ — Convertible Note Payable (q) *** $ 53,000 2/26/2019 2/20/2020 22.00 % $ 79,500 $ — Convertible Note Payable (r) $ 75,000 3/18/2019 12/13/2019 12.00 % $ 75,000 $ — Convertible Note Payable (s) *** $ 38,000 5/2/2019 4/29/2020 22.00 % 57,000 Subtotal $ 708,647 $ 719,000 Debt Discount $ (212,597 ) $ (165,186 ) Balance, net $ 496,050 $ 553,814 Less current portion $ (488,141 ) $ (161,280 ) Total long-term $ 7,909 $ 392,534 * Embedded conversion feature accounted for as a derivative liability

DERIVATIVE AND PREFERRED STOC_2

DERIVATIVE AND PREFERRED STOCK LIABILITIES (Tables)	6 Months Ended
	Jun. 30, 2019
Notes to Financial Statements
Summary of changes in the fair value of the Company's Level 3 financial liabilities	June 30, 2019 December 31, 2018 Balance at the beginning of period $ 322,976 $ — Original discount limited to proceeds of notes 331,750 100,000 Fair value of derivative liabilities in excess of notes proceeds received 749,825 247,033 Settlement of derivative instruments (257,268 ) — Change in fair value of embedded conversion option 2,201,816 (24,057 ) Balance at the end of the period $ 3,349,099 $ 322,976
Assumptions used in the calculations for fair value of derivative liabilities	Expected Volatility Risk-free Interest Rate Expected Dividend Yield Expected Life (in years) At issuance 128-301% 2.11-2.51% 0 % 0.49-5.00 At June 30, 2019 160-336% 1.71-2.23% 0 % 0.32-4.71
Assumptions used in the calculations for fair value of preferred stock liabilities	Expected Volatility Risk-free Interest Rate Expected Dividend Yield Expected Life (in years) At April 12, 2019 170% 2.36% 0 % 3.00

STOCKHOLDERS' DEFICIT AND STO_2

STOCKHOLDERS' DEFICIT AND STOCK OPTIONS (Tables)	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
Summary of options issued and outstanding	Number of Weighted average exercise price Balance, December 31, 2018 2,287,500 0.34 Granted — — Expired (1,905,000 ) 0.16 Settled — — Balance, June 30, 2019 382,500 1.24
Stock options outstanding	Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 01/01/2016 75,000 75,000 0.33 0.50 12/31/2019 25,000 01/01/2016 90,000 90,000 0.33 0.50 12/31/2019 30,000 09/15/2016 10,000 10,000 1.00 0.50 12/31/2019 10,000 10/01/2016 7,500 7,500 1.00 0.50 12/31/2019 7,500 01/26/2017 200,000 200,000 2.00 2.58 01/26/2022 400,000 382,500 382,500 $ 472,500

WARRANTS (Tables)

WARRANTS (Tables)	6 Months Ended
	Jun. 30, 2019
Guarantees and Product Warranties [Abstract]
Summary of the continuity of share purchase warrants	Number of Weighted average exercise price Balance, December 31, 2018 650,000 0.17 Adjustment to warrants outstanding 420,891,071 0.00035 Granted 487,500 0.20 Settled (100,000 ) 0.10 Balance, June 30, 2019 421,928,571 0.00047
Share purchase warrants outstanding	Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 11/28/2018 142,857,143 * 142,857,143 * 0.00035 * 2.42 11/28/2021 $ 50,000 12/3/2018 500,000 500,000 0.10 4.43 12/3/2023 50,000 2/14/2018 171,428,571 * 171,428,571 * 0.00035 * 4.63 2/14/2024 60,000 3/13/2018 107,142,857 * 107,142,857 * 0.00035 * 4.71 3/13/2024 37,500 421,928,571 421,928,571 $ 197,500

BASIS OF PRESENTATION AND SUM_4

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Financial assets and liabilities carried at fair value measured on a recurring basis (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018	Dec. 31, 2017
Preferred series A stock liability		$ 144,352
Derivative liability	$ 3,349,099	322,976
Total	3,349,099	467,328
Quoted prices in active markets (Level 1)
Preferred series A stock liability
Derivative liability
Total
Significant other observable inputs (Level 2)
Preferred series A stock liability
Derivative liability
Total
Significant unobservable inputs (Level 3)
Preferred series A stock liability		144,352
Derivative liability	3,349,099	322,976
Total	$ 3,349,099	$ 467,328

BASIS OF PRESENTATION AND SUM_5

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2016	Dec. 31, 2018	Dec. 31, 2017
Nature of Operations
Company common stock issued to Paradigm shareholders, shares			16,790,625
Paradigm common stock acquired in Securities Exchange Agreement, shares			22,387,500
Company options issued to Paradigm shareholders, shares exercisable			2,040,000
Paradigm options received in Securities Exchange Agreement, shares			2,720,000
Cash	$ 37,298	$ 53		$ 4,893	$ 7,838
Cash equivalents
Allowance for doubtful accounts
Reserve allowance for inventory
Balance of supplies and equipment not yet placed in service	306,225			$ 319,735
Impairment expense
Antidilutive securities excluded from calculation of earnings per share	721,585,416
Exercise price, minimum
Nature of Operations
Exercise prices of options issued			$ 0.133
Exercise prices of options received			0.10
Exercise price, maximum
Nature of Operations
Exercise prices of options issued			0.333
Exercise prices of options received			$ 0.25

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Losses incurred since inception	$ (14,377,473)	$ (9,927,003)
Working capital	$ (5,837,607)

PROPERTY AND EQUIPMENT - Proper

PROPERTY AND EQUIPMENT - Property and equipment (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Property, Plant and Equipment [Abstract]
Machinery and leased equipment	$ 151,719	$ 138,209
Machinery and equipment not yet in services	358,760	369,754
Office equipment and furniture	20,064	20,064
Website	2,760	2,760
Total Property and equipment	533,303	530,787
Less: Accumulated depreciation	(43,516)	(30,815)
Property and equipment, net	$ 489,787	$ 499,972

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Property, Plant and Equipment [Abstract]
Depreciation expense	$ (12,701)	$ (12,946)

INTANGIBLE ASSETS - Components

INTANGIBLE ASSETS - Components of intangible assets (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Patents	$ 4,505,489	$ 4,514,989
Technology rights	200,000	235,500
Intangible, at cost	4,705,489	4,750,489
Less: Accumulated amortization	(844,616)	(690,714)
Net Carrying Amount	$ 3,860,873	$ 4,059,775

INTANGIBLE ASSETS - Estimated f

INTANGIBLE ASSETS - Estimated future amortization expense of intangible assets (Details)	Jun. 30, 2019USD ($)
Intangible Assets - Estimated Future Amortization Expense Of Intangible Assets
For year ending December 31, 2019	$ 155,168
For year ending December 31, 2020	303,613
For year ending December 31, 2021	302,003
For year ending December 31, 2022	302,003
For year ending December 31, 2023 to December 31, 2034	2,798,086
Total	$ 3,860,873

INTANGIBLE ASSETS (Details Narr

INTANGIBLE ASSETS (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Intangible Assets Details Narrative Abstract
Amortization expense	$ (156,400)	$ (153,912)

LEASES - ROU assets and liabili

LEASES - ROU assets and liabilities (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Operating lease right-of-use asset	$ 19,695
Operating lease liability:
Current operating lease liability	21,704
Noncurrent operating lease liability
Total operating lease liability	$ 21,704

LEASES - Remaining lease paymen

LEASES - Remaining lease payments (Details)	Jun. 30, 2019USD ($)
Debt Disclosure [Abstract]
2019 - remaining	$ 24,000
2020 and thereafter
Total lease payments	24,000
Less: imputed interest	(2,296)
Total ROU liabilities	$ 21,704

LEASES - Minimum payments under

LEASES - Minimum payments under operating lease agreements (Details)	Dec. 31, 2018USD ($)
Debt Disclosure [Abstract]
2019	$ 52,950
2020
Total	$ 52,950

LEASES (Details Narrative)

LEASES (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Net lease assets		$ 43,330
Net lease liabilities		$ 43,330
Operating lease expense recognized	$ 30,809
Amounts paid included in measurement of operating lease liabilities	28,800
Decrease in ROU liabilities from cash paid	$ (21,626)

NOTES PAYABLE - Notes payable (

NOTES PAYABLE - Notes payable (Details)	6 Months Ended
	Jun. 30, 2019USD ($)
Notes Payable (1)
Original amount	$ 150,000
Issuance date	May 18, 2016
Maturity date	Jun. 1, 2019
Interest rate	19.00%
Balance, beginning	$ 150,000
Balance, ending	150,000
Notes Payable (4)
Original amount	$ 25,000
Issuance date	May 8, 2017
Maturity date	Jun. 30, 2018
Interest rate	0.00%
Balance, beginning	$ 27,500
Balance, ending	27,500
Notes Payable (14)
Original amount	$ 130,000
Issuance date	Jun. 20, 2018
Maturity date	Jan. 2, 2020
Interest rate	8.00%
Balance, beginning	$ 130,000
Balance, ending	130,000
Notes Payable (15)
Original amount	$ 126,964
Issuance date	Jun. 20, 2018
Maturity date	Aug. 31, 2018
Interest rate	60.00%
Balance, beginning	$ 126,964
Balance, ending
Notes Payable (16)
Original amount	$ 26,500
Issuance date	Jun. 26, 2018
Maturity date	Oct. 1, 2019
Interest rate	10.00%
Balance, beginning	$ 26,500
Balance, ending	10,090
Notes Payable (17)
Original amount	$ 60,000
Issuance date	Oct. 30, 2018
Maturity date	Dec. 30, 2018
Interest rate	8.00%
Balance, beginning	$ 60,000
Balance, ending
Notes Payable (18)
Original amount	$ 8,700
Issuance date	Nov. 15, 2018
Maturity date	Jun. 30, 2019
Interest rate	10.00%
Balance, beginning	$ 8,700
Balance, ending	8,700
Notes Payable (19)
Original amount	$ 52,063
Issuance date	Apr. 8, 2020
Maturity date	Apr. 8, 2020
Interest rate	41.38%
Balance, beginning
Balance, ending	42,854
Notes Payable (20)
Original amount	$ 40,000
Issuance date	Jun. 20, 2019
Maturity date	Dec. 31, 2019
Interest rate	8.00%
Balance, beginning
Balance, ending	40,000
Notes Payable (21)
Original amount	$ 6,741
Issuance date	Jun. 21, 2019
Maturity date	Apr. 8, 2020
Interest rate	41.38%
Balance, beginning
Balance, ending	6,741
Notes Payable, Related Party (12)
Original amount	$ 30,000
Issuance date	Apr. 10, 2018
Maturity date	Jan. 15, 2019
Interest rate	3.00%
Balance, beginning	$ 30,000
Balance, ending	30,000
Notes Payable, Related Party (14)
Original amount	$ 380,000
Issuance date	Jun. 20, 2018
Maturity date	Jan. 2, 2020
Interest rate	8.00%
Balance, beginning	$ 380,000
Balance, ending	380,000
Notes Payable, Related Party (15)
Original amount	$ 350,000
Issuance date	Jun. 20, 2018
Maturity date	Jan. 2, 2020
Interest rate	5.00%
Balance, beginning	$ 350,000
Balance, ending	339,000
Notes Payable, Related Party (16)
Original amount	$ 17,000
Issuance date	Jun. 20, 2018
Maturity date	Jan. 2, 2020
Interest rate	5.00%
Balance, beginning	$ 17,000
Balance, ending	17,000
Notes Payable, Related Party (18)
Original amount	$ 50,000
Issuance date	Jul. 27, 2018
Maturity date	Nov. 30, 2018
Interest rate	8.00%
Balance, beginning	$ 50,000
Balance, ending	50,000
Notes Payable, Related Party (19)
Original amount	$ 5,000
Issuance date	Oct. 9, 2018
Interest rate	0.00%
Balance, beginning	$ 5,000
Balance, ending	5,000
Notes Payable, Related Party (20)
Original amount	$ 5,000
Issuance date	Oct. 19, 2018
Interest rate	0.00%
Balance, beginning	$ 5,000
Balance, ending	5,000
Notes Payable, Related Party (22)
Original amount	$ 3,000
Issuance date	Oct. 24, 2018
Interest rate	0.00%
Balance, beginning	$ 3,000
Balance, ending
Notes Payable, Related Party (23)
Original amount	$ 2,544
Issuance date	Jan. 3, 2019
Maturity date	Jun. 30, 2019
Interest rate	3.00%
Balance, beginning
Balance, ending
Convertible Note Payable (1)
Original amount	$ 450,000
Issuance date	Mar. 28, 2018
Maturity date	Mar. 31, 2021
Interest rate	8.00%
Balance, beginning	$ 450,000
Balance, ending
Convertible Note Payable (2)
Original amount	$ 539,936
Issuance date	Jan. 15, 2019
Maturity date	Jan. 15, 2022
Interest rate	8.00%
Balance, beginning
Balance, ending
Convertible Note Payable (3)
Original amount	$ 38,000
Issuance date	Jul. 25, 2018
Maturity date	Jul. 25, 2019
Interest rate	12.00%
Balance, beginning	$ 38,000
Balance, ending
Convertible Note Payable (4)
Original amount	$ 53,000
Issuance date	Aug. 27, 2018
Maturity date	Aug. 27, 2019
Interest rate	12.00%
Balance, beginning	$ 53,000
Balance, ending
Convertible Note Payable (5)
Original amount	$ 50,000
Issuance date	Dec. 6, 2018
Maturity date	Dec. 6, 2019
Interest rate	5.00%
Balance, beginning	$ 50,000
Balance, ending	36,123
Convertible Note Payable (6)
Original amount	$ 65,000
Issuance date	Dec. 6, 2018
Maturity date	Dec. 6, 2019
Interest rate	5.00%
Balance, beginning	$ 65,000
Balance, ending	43,599
Convertible Note Payable (7)
Original amount	$ 63,000
Issuance date	Dec. 12, 2018
Maturity date	Dec. 5, 2019
Interest rate	22.00%
Balance, beginning	$ 63,000
Balance, ending	42,800
Convertible Note Payable (8)
Original amount	$ 33,000
Issuance date	Jan. 16, 2019
Maturity date	Jan. 15, 2020
Interest rate	22.00%
Balance, beginning
Balance, ending	49,500
Convertible Note Payable (9)
Original amount	$ 100,000
Issuance date	Jan. 18, 2019
Maturity date	Jan. 16, 2020
Interest rate	8.00%
Balance, beginning
Balance, ending	100,000
Convertible Note Payable (10)
Original amount	$ 60,000
Issuance date	Jan. 29, 2019
Maturity date	Jan. 22, 2020
Interest rate	8.00%
Balance, beginning
Balance, ending	60,000
Convertible Note Payable (11)
Original amount	$ 50,000
Issuance date	Feb. 1, 2019
Maturity date	Oct. 22, 2019
Interest rate	12.00%
Balance, beginning
Balance, ending	50,000
Convertible Note Payable (12)
Original amount	$ 60,000
Issuance date	Feb. 21, 2019
Maturity date	Feb. 14, 2022
Interest rate	0.00%
Balance, beginning
Balance, ending	60,000
Convertible Note Payable (13)
Original amount	$ 55,125
Issuance date	Feb. 21, 2019
Maturity date	Feb. 20, 2020
Interest rate	8.00%
Balance, beginning
Balance, ending	55,125
Convertible Note Payable (14)
Original amount	$ 53,000
Issuance date	Feb. 26, 2019
Maturity date	Feb. 20, 2020
Interest rate	22.00%
Balance, beginning
Balance, ending	79,500
Convertible Note Payable (15)
Original amount	$ 75,000
Issuance date	Mar. 18, 2019
Maturity date	Dec. 13, 2019
Interest rate	12.00%
Balance, beginning
Balance, ending	75,000
Convertible Note Payable (16)
Original amount	$ 38,000
Issuance date	May 2, 2019
Maturity date	Apr. 29, 2020
Interest rate	22.00%
Balance, beginning
Balance, ending	$ 57,000

DERIVATIVE AND PREFERRED STOC_3

DERIVATIVE AND PREFERRED STOCK LIABILITIES - Summary of changes in the fair value of the Company's Level 3 financial liabilities (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Notes to Financial Statements
Balance at the beginning of period	$ 322,976
Original discount limited to proceeds of notes	331,750	100,000
Fair value of derivative liabilities in excess of notes proceeds received	749,825	247,033
Settlement of derivative instruments	(257,268)
Change in fair value of embedded conversion option	2,201,816	(24,057)
Balance at the end of the period	$ 3,349,099	$ 322,976

DERIVATIVE AND PREFERRED STOC_4

DERIVATIVE AND PREFERRED STOCK LIABILITIES - Assumptions used in the calculations for fair value of derivative liabilities (Details)	6 Months Ended
	Jun. 30, 2019
Derivative liabilities - At Issuance
Expected price volatility, minimum	128.00%
Expected price volatility, maximum	301.00%
Expected dividend yield	0.00%
Expected option life, minimum	5 months 27 days
Expected option life, maximum	5 years
Risk-free interest rate, minimum	2.11%
Risk-free interest rate, maximum	2.51%
Derivative liabilities
Expected price volatility, minimum	160.00%
Expected price volatility, maximum	336.00%
Expected dividend yield	0.00%
Expected option life, minimum	3 months 26 days
Expected option life, maximum	4 years 8 months 16 days
Risk-free interest rate, minimum	1.71%
Risk-free interest rate, maximum	2.23%

DERIVATIVE AND PREFERRED STOC_5

DERIVATIVE AND PREFERRED STOCK LIABILITIES - Assumptions used in the calculations for fair value of preferred stock liabilities (Details) - Preferred stock liability	6 Months Ended
	Jun. 30, 2019
Expected price volatility, maximum	170.00%
Expected dividend yield	0.00%
Expected option life, maximum	3 years
Risk-free interest rate, maximum	2.36%

DERIVATIVE AND PREFERRED STOC_6

DERIVATIVE AND PREFERRED STOCK LIABILITIES (Details Narrative)	6 Months Ended
	Jun. 30, 2019USD ($)
Notes to Financial Statements
Fair value of preferred series A stock liability	$ 144,352
Loss on change in fair value of preferred shares	$ (55,830)

STOCKHOLDERS' DEFICIT AND STO_3

STOCKHOLDERS' DEFICIT AND STOCK OPTIONS - Summary of options issued and outstanding (Details)	6 Months Ended
	Jun. 30, 2019$ / sharesshares
Stockholders Deficit And Stock Options - Summary Of Options Issued And Outstanding
Number of options, beginning balance | shares	2,287,500
Number of options, granted | shares
Number of options, expired | shares	(1,905,000)
Number of options, settled | shares
Number of options, ending balance | shares	382,500
Weighted average exercise price, beginning balance | $ / shares	$ 0.34
Weighted average exercise price, granted | $ / shares
Weighted average exercise price, expired | $ / shares	0.16
Weighted average exercise price, settled | $ / shares
Weighted average exercise price, ending balance | $ / shares	$ 1.24

STOCKHOLDERS' DEFICIT AND STO_4

STOCKHOLDERS' DEFICIT AND STOCK OPTIONS - Stock options outstanding (Details) - USD ($)	Jan. 27, 2017	Oct. 02, 2016	Sep. 16, 2016	Jan. 02, 2016	Jun. 30, 2019
Options issued and outstanding
Number outstanding	200,000	7,500	10,000	75,000	382,500
Number exercisable	200,000	7,500	10,000	75,000	382,500
Exercise price	$ 2	$ 1	$ 1	$ 0.33
Weighted average remaining contractual life	2 years 6 months 29 days	6 months	6 months	6 months
Expiration date	Jan. 26, 2022	Dec. 31, 2019	Dec. 31, 2019	Dec. 31, 2019
Proceeds to Company if exercised	$ 400,000	$ 7,500	$ 10,000	$ 25,000	$ 472,500
Options issued and outstanding (2)
Number outstanding				90,000
Number exercisable				90,000
Exercise price				$ 0.33
Weighted average remaining contractual life				6 months
Expiration date				Dec. 31, 2019
Proceeds to Company if exercised				$ 30,000

STOCKHOLDERS' DEFICIT AND STO_5

STOCKHOLDERS' DEFICIT AND STOCK OPTIONS (Details Narrative)	6 Months Ended
	Jun. 30, 2019USD ($)$ / sharesshares
Equity [Abstract]
Conversion of principal and interest of notes payable into common stock, amount	$ 215,305
Conversion of principal and interest of notes payable into common stock, shares | shares	27,329,334
Common stock issued in lieu of compensation, shares | shares	200,000
Common stock issued in lieu of compensation, fair value recorded in consulting expense	$ 34,000
Settlement agreement with consultant, common stock issued, shares | shares	3,597,989
Settlement agreement with consultant, loss on settlement of debt recognized	$ (55,830)
Stock Options
Weighted average exercise prices of options outstanding | $ / shares	$ 1.24
Weighted average exercise prices of options exercisable | $ / shares	$ 1.24
Instrinsic value of stock options outstanding

WARRANTS - Summary of the conti

WARRANTS - Summary of the continuity of share purchase warrants (Details)	6 Months Ended
	Jun. 30, 2019$ / sharesshares
Guarantees and Product Warranties [Abstract]
Number of warrants, beginning balance | shares	650,000
Number of warrants, adjustments to warrants outstanding | shares	420,891,071
Number of warrants, granted | shares	487,500
Number of warrants, settled | shares	(100,000)
Number of warrants, ending balance | shares	421,928,571
Weighted average exercise price, beginning balance | $ / shares	$ .17
Weighted average exercise price, adjustments to warrants outstanding | $ / shares	0.00035
Weighted average exercise price, granted | $ / shares	.20
Weighted average exercise price, settled | $ / shares	.10
Weighted average exercise price, ending balance | $ / shares	$ 0.00047

WARRANTS - Share purchase warra

WARRANTS - Share purchase warrants outstanding (Details) - Share purchase warrants outstanding - USD ($)	Mar. 14, 2019	Feb. 15, 2019	Dec. 04, 2018	Nov. 29, 2018	Jun. 30, 2019
Number outstanding	107,142,857	171,428,571	500,000	142,857,143	421,928,571
Number exercisable	107,142,857	171,428,571	500,000	142,857,143	421,928,571
Exercise price	$ 0.00035	$ 0.00035	$ 0.10	$ 0.00035
Weighted average remaining contractual life	4 years 8 months 16 days	4 years 7 months 17 days	4 years 5 months 5 days	2 years 5 months 1 day
Expiration date	Mar. 13, 2024	Feb. 14, 2024	Dec. 3, 2023	Nov. 28, 2021
Proceeds to Company if exercised	$ 37,500	$ 60,000	$ 50,000	$ 50,000	$ 197,500

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Annual base salary for director to serve as president of Annihilyzer Division of Paradigm		$ 90,000
Signing bonus due to Division president		$ 40,000
Purchase agreement initial payment amount	$ 5,000
Consulting agreement (3)
Monthly consulting fee	1,250
Initial fee	5,000
Consulting agreement (4)
Monthly consulting fee	2,500
Initial fee	$ 5,000
Shares issued for services	2,000,000
Consulting agreement (6)
Shares issued for services	1,000,000
Consulting agreement (7)
Shares issued for services	100,000